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Abstract
The obligate intracellular pathogens Plasmodium falciparum and Toxoplasma gondii remodel their host
cell to facilitate their intracellular development and progress through their asexual life cycle, a virulent
lytic cycle responsible for parasite-mediated pathogenesis. While several studies have highlighted
parasite proteins that interact with the host cell during this cycle, host proteins exploited by the parasite
for successful growth and conversely, host molecules evolutionarily tuned to control parasite infection
remain unclear. We addressed this question from both sides of the host-parasite interaction in the hope to
leverage biological discovery of host molecules involved in infection into the validation of novel drug
target candidates with vastly reduced potential for resistance: (1) building on previously established roles
of host calpain during the lytic cycle to elucidate host pathways that facilitate parasite life cycle
progression and (2) clarifying the existing role of platelets in innate control of parasitic disease.
Comparative proteomics, genetics, and biochemical techniques led us to the discovery of a complex Gaqcoupled, protein kinase C (PKC)-mediated host signaling cascade common to both T. gondii and P.
falciparum that results in cytoskeletal compromise and facilitates host calpain activation immediately
prior to parasite release (Millholland et al., 2011; Millholland et al., 2013). The complexity of this pathway
represented an untapped resource of antimalarial targets; indeed, inhibitors of key host signaling
components demonstrated antiparasitic activity in murine models of malaria and toxoplasmosis.
Conversely, host platelets were previously shown to have antimalarial capacity, leading us to characterize
this host-parasite interaction in the hope to harness this antimalarial activity to optimize therapeutic
potential. Upon screening molecules secreted in the blood stream, we identified Platelet Factor 4 as the
host defense peptide (HDP) component of platelets capable of killing malaria parasites via selective lysis
of the parasite digestive vacuole (DV), the site of hemoglobin digestion(Love et al., 2012). To exploit this
DV lysis mechanism in a drug discovery effort, we tested a library of small, nonpeptidic mimics of HDPs
and identified compounds that potently killed P. falciparum in vitro and reduced parasitemia in a murine
malaria model. Taken together, these data reinforce the feasibility of targeting host molecules as a novel
antiparasitic strategy.
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ABSTRACT
HOST-APICOMPLEXAN PARASITE INTERACTIONS:
LEVERAGING BIOLOGICAL DISCOVERY INTO ANTIPARASITIC DRUG DEVELOPMENT
Melanie G. Millholland
Doron C. Greenbaum

The obligate intracellular pathogens Plasmodium falciparum and Toxoplasma gondii
remodel their host cell to facilitate their intracellular development and progress through
their asexual life cycle, a virulent lytic cycle responsible for parasite-mediated
pathogenesis. While several studies have highlighted parasite proteins that interact with
the host cell during this cycle, host proteins exploited by the parasite for successful
growth and conversely, host molecules evolutionarily tuned to control parasite infection
remain unclear. We addressed this question from both sides of the host-parasite
interaction in the hope to leverage biological discovery of host molecules involved in
infection into the validation of novel drug target candidates with vastly reduced potential
for resistance: (1) building on previously established roles of host calpain during the lytic
cycle to elucidate host pathways that facilitate parasite life cycle progression and (2)
clarifying the existing role of platelets in innate control of parasitic disease. Comparative
proteomics, genetics, and biochemical techniques led us to the discovery of a complex
Gaq-coupled, protein kinase C (PKC)-mediated host signaling cascade common to both
T. gondii and P. falciparum that results in cytoskeletal compromise and facilitates host
calpain activation immediately prior to parasite release (Millholland et al., 2011;
Millholland et al., 2013). The complexity of this pathway represented an untapped
resource of antimalarial targets; indeed, inhibitors of key host signaling components
demonstrated antiparasitic activity in murine models of malaria and toxoplasmosis.
Conversely, host platelets were previously shown to have antimalarial capacity, leading
us to characterize this host-parasite interaction in the hope to harness this antimalarial
activity to optimize therapeutic potential. Upon screening molecules secreted in the
blood stream, we identified Platelet Factor 4 as the host defense peptide (HDP)
component of platelets capable of killing malaria parasites via selective lysis of the
parasite digestive vacuole (DV), the site of hemoglobin digestion(Love et al., 2012). To
exploit this DV lysis mechanism in a drug discovery effort, we tested a library of small,
nonpeptidic mimics of HDPs and identified compounds that potently killed P. falciparum
in vitro and reduced parasitemia in a murine malaria model. Taken together, these data
reinforce the feasibility of targeting host molecules as a novel antiparasitic strategy.
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INTRODUCTION
Apicomplexan Parasite Biology
	
  
Intracellular parasites of the phylum Apicomplexa cause significant morbidity and
mortality worldwide. Toxoplasma gondii is a highly successful protozoan parasite,
chronically infecting an estimated 30% of the world’s population (Weiss and Dubey,
2009). Including many water-borne protozoa that can threaten human health via
accidental or intentional contamination of public water supplies, such as the class B
biodefense agents Toxoplasma gondii, Cryptosporidium hominis, and Cryptosporidium
parvum, this phylum is also a home to the malaria parasite Plasmodium falciparum,
which continues to be a devastating disease and a global health burden responsible for
>500 million clinical cases of malaria that result in >1 million deaths each year (Gething
et al., 2011). No completely satisfactory therapies exist for treating infection by these
parasites: hypersensitivity to sulfonamides and lincosamides limits their utility against T.
gondii, particularly in immunocompromised patients, and there is no effective chemotherapy for acute cryptosporidiosis. While vector control may reduce malaria parasite
prevalence, chemotherapy remains the principal means of controlling disease.
Unfortunately, the emergence and spread of drug-resistant P. falciparum, the parasite
that causes the most deaths, has rendered most of the traditional antimalarials (e.g.
chloroquine) clinically ineffective, necessitating the discovery of novel antimalarials.
Ideally, novel treatments will minimize resistance, though most approaches to develop
therapeutics generate resistant parasites in the lab and field.
Most Apicomplexan parasites are obligate intracellular pathogens that traverse a
complex life cycle, including both sexual and asexual stages. The chronic asexual phase
1	
  
	
  

includes a virulent lytic cycle responsible for parasite-mediated pathogenesis. During this
lytic cycle, parasites (Plasmodium merozoites, T. gondii tachyzoites) divide inside a
parasite-modified vacuole following host cell invasion (the parasitophorous vacuole or
PV). To do this they must dramatically remodel their host cell to facilitate invasion,
intracellular development, avoid host defenses, and finally to exit from their host cell to
renew the lytic cycle. Recently, there have been several studies investigating parasite
proteins that interact with host proteins during the lytic cycle, but there is far less known
about host proteins necessary for parasite growth.
Host-Pathogen Interactions Necessary for Survival: Getting In and Getting Out
The asexual phase of the intracellular cycle is comprised of a lytic cycle in which
parasites invade a host cell and then establish an intracellular niche within a particular
host cell type (Toxoplasma gondii infects any nucleated animal cell, Cryptosporidium
parvum

specifically

infects

enterocytes

while

Plasmodium

falciparum

infects

erythrocytes). To initiate the intracellular cycle, parasites first attach to the host cell via
low affinity interaction and actively reorient so that the end with apical organelles is
pointed inwards towards the host cell. Parasite ligand interactions with host receptors
cause irreversible attachment, which engages the parasite actin/myosin motor system to
pull the host membrane around the parasite. Completion of invasion involves the sealing
of the membrane to create a PV within which the parasite divides and completes its
entire intracellular cycle. After replication is complete, the daughter parasites must exit
from this PV and also the host cell in order to invade uninfected cells and continue the
infection anew (Glushakova et al., 2005; Salmon et al., 2001). Many parasite-derived
proteins, including proteases (Brossier et al., 2005; Buguliskis et al., 2010; Starnes et al.,
2009), kinases (Carruthers et al., 1999; Straub et al., 2011; Sugi et al., 2010) and
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surface ligands (Brossier et al., 2003; Carruthers et al., 1999; Carruthers et al., 2000)
have been implicated as necessary for invasion. Knockdown or inhibition of many of
these proteins has been shown to prevent parasite invasion and cause parasite death.
Though parasite proteins required for invasion have been studied in detail, very little is
understood on the host side, aside from a recent finding that invasion of T. gondii
tachyzoites is dependent on host actin polymerization (Gonzalez et al., 2009), as
mediated by interaction with a parasite-derived secreted actin-binding protein (toxofilin),
which facilitates host cell actin filament disassembly and turnover (Delorme-Walker et
al., 2012). Thus, invasion has proven to be a critical phase for therapeutic intervention,
as parasites unable to invade are not only unable to replicate, these stranded parasites
have been shown to die within hours of failed invasion (Buguliskis et al., 2010; Larson et
al., 2009; Lovett and Sibley, 2003; Poupel and Tardieux, 1999; Sibley and Andrews,
2000; Teo et al., 2007).
Once a parasite successfully invades a host cell, it initiates major changes in its new
environment. This is best illustrated by the extreme alterations P. falciparum parasites
make to their new, and transient, home in a host erythrocyte. P. falciparum infection
reduces deformability (Maier et al., 2008) and changes the adhesive properties of the
host erythrocyte, due to the appearance of knob-like protrusions on the surface (Crabb
et al., 1997; Sherman et al., 1992; Smith et al., 1992) and specialized secretion of
parasite proteins into the host cell (Hiller et al., 2004; Marti et al., 2005). Yet perhaps the
most profound change to the erythrocyte is its complete collapse at the end of the
parasite erythrocytic cycle, as the newly replicated merozoites are released (Glushakova
et al., 2005). For many years, parasite proteases have been thought to be important for
rupture of malaria parasites from host cells (Hadley et al., 1983): from initial inhibitor	
   3	
  
	
  

based data, a two-step model of parasite rupture was proposed, requiring the activity of
a cysteine and possibly a serine protease, as the general cysteine protease inhibitor E64
and the cysteine/serine protease inhibitors leupeptin and chymostatin inhibited PV and
erythrocyte plasma membrane rupture, respectively (Glushakova et al., 2009; Salmon et
al., 2001; Wickham et al., 2003a). More recently, several reports have implicated the
involvement of three proteases in the rupture process: the parasite-derived proteases
PfDPAP3 (Arastu-Kapur et al., 2008) and PfSub1 (Yeoh et al., 2007), and the human
protease calpain-1 (Chandramohanadas et al., 2009). In addition to proteolytic enzymes,
it has also been established that osmotic forces (Glushakova et al., 2010), changes in
parasite calcium flux (Nagamune et al., 2008), pore-forming proteins (Kafsack et al.,
2009),

and a kinase (Dvorin et al., 2010) are important for efficient egress of

apicomplexan family parasites.
Although these studies have provided details on a variety of parasite proteins that act
or are proteolytically processed during egress (Bowyer et al., 2010), we hypothesized
that the parasite likely modifies host erythrocyte proteins and specifically needs to
destabilize the host cytoskeletal-membrane network to efficiently exit from the host cell,.
Thus, we were interested in a more comprehensive understanding of changes to the
infected erythrocyte membrane and cytoskeleton proteomes as the parasites prepare
the host cell for rupture and merozoite exit.
Egress of both P. falciparum (Wickham et al., 2003a) and the related apicomplexan,
T. gondii (Black et al., 2000; Lavine et al., 2007), has been shown to be a Ca2+dependent process, inducing secretion of parasite-derived pore-forming proteins and
activation of host-derived proteases. Ca2+ dynamics during egress have been best
described within T. gondii: (i) It is well established that T. gondii egress can be induced
via treatment with the calcium ionophore A23187 (Endo et al., 1982). (ii) T. gondii egress
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has been shown to be controlled by a plant-like pathway for cyclic adenosine
diphosphate ribose (cADPR) production through accumulation of abscisic acid, which
results in elevated Ca2+ levels that stimulate egress (Chini et al., 2005; Nagamune et al.,
2008), and (iii) Ca2+-induced micronemal secretion of TgPLP-1, a perforin-like protein,
has been shown to aid in lysis of the PV membrane during T. gondii egress (Kafsack et
al., 2009). We have recently discovered that apicomplexan parasites co-opt the Ca2+regulated host cysteine protease calpain to allow for egress from the host cell
(Chandramohanadas et al., 2009). In both P. falciparum and T. gondii, calpain was
shown to be necessary for egress, as it is specifically activated just prior to parasite
egress and is involved in the cleavage of several cytoskeletal proteins including α/βspectrin and ankyrin. Pharmacological inhibition or depletion of calpain from host
erythrocytes led to a robust block in parasite egress, thus limiting life cycle progression.
Recent work on T. gondii has implicated a perforin-like protein (TgPLP-1) as critical for
egress (Kafsack et al., 2009). TgPLP-1 is a pore-forming protein similar to that used by
cytotoxic T lymphocytes (CTL) for target cell killing (Voskoboinik et al., 2006). Perforin
secretion by CTLs is thought to allow Ca2+ and granzyme entry, leading to target cell
death (Chowdhury and Lieberman, 2008), which may link this parasite protein to host
Ca2+ signaling, as Ca2+ within the parasite may traverse this pore and mobilize into the
host cell to activate a Ca2+ signaling pathway. TgPLP-1 KO parasites are crippled in
vitro, and unable to establish infection in a mouse model, indicating the importance of
this protein and the process of egress in the parasite survival. Deposition of this protein
is necessary for efficient egress from host cells, as TgPLP-1 KO parasites fail to egress
normally from the PV and host cell membranes. Strikingly, co-infection of host cells with
both WT parasites and TgPLP-1 KO parasites abrogates the egress defect in the KO
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parasite, thus implicating the likelihood of a parasite-induced freely diffusible second
messenger in the host cell, which activates a common host-derived egress pathway
allowing both parasites to exit.
Platelets, Malaria, and Host Defense Peptides (HDPs): the Other Side of the Coin.
In addition to interactions with the host that facilitate parasite survival, hosts have
developed numerous defenses against these invading pathogens that have spanned
evolutionary time, efficiently overcoming the barrage of potential invaders. Recent work
has shown that platelets can bind infected erythrocytes and kill the intracellular malaria
parasite (McMorran et al., 2009). Platelets have been long known to interact
cooperatively with erythrocytes in thrombogenesis, both generally and in the specific
case of sickle cell disease (Rocca and FitzGerald, 1997), though previous studies have
suggested that thrombocytopenia is a poor prognostic marker in malaria (Moerman et
al., 2003) and significantly associated with cerebral malaria (Cox and McConkey, 2010;
Wassmer et al., 2008).
Based on the knowledge surrounding possible interactions between platelets and P.
falciparum and prior data that platelets contain HDP-like proteins (Tang et al., 2002), we
hypothesized that perhaps innate immune proteins such as HDP-containing proteins that
are found in either platelets could be natural antiparasitics and were likely optimized
against these pathogens following years of concomitant evolution. Antiparasitic activities
have been reported for a number of HDPs and are thought to kill protozoa, though the
physiological significance of the reported interactions is questionable (Mangoni et al.,
2005; Vizioli and Salzet, 2002). The HDPs that have previously been studied,
dermaseptins, are not present in blood or cells that circulate in the blood and kill intraerythrocytic parasites by disrupting the erythrocyte plasma membrane of infected
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erythrocytes rather than directly killing parasites (Feder et al., 2000; Krugliak et al.,
2000).
HDPs play a central role in the innate immune system (Finlay and Hancock,
2004; Hancock and Lehrer, 1998; Tossi et al., 2000; Zasloff, 2002). There are two types
of HDPs comprising ribosomally and nonribosomally synthesized peptides. Over 700
HDPs have been identified, varying in length (12 - 80 residues), sequence, and threedimensional structure. The two major classes of HDPs are α-helical (magainin and
cecropin) and disulfide-rich β-sheets (bactenecin and defensin), although other tertiary
structures also exist. HDPs are particularly important in insects and plants, which lack an
adaptive immune response based on T-cells and antibodies. Further, HDPs display very
broad-spectrum action against bacteria, fungi, protozoa, and even viruses, which has
promoted their use as new leads for developing antibiotics (Zasloff, 2002).
HDPs share common features including highly amphiphilic topologies in which
the hydrophilic and hydrophobic side chains segregate onto distinctly opposing regions
or faces of the overall folded conformation. Numerous studies with linear and cyclic
peptides have strongly supported the hypothesis that the physicochemical properties of
HDPs, rather than any specific sequence or structure, are responsible for their activities.
It is generally believed that this amphiphilic topology is essential for insertion into and
disruption of the cytoplasmic membrane leading to patogen death (Zasloff, 2002).
However, it is important to remember that while these compounds primarily target
membranes, specific HDPs can interact with other components of the innate immune
system (reviewed in (Finlay and Hancock, 2004)) and many HDPs appear to act on
additional protein and nucleic acid targets (del Castillo et al., 2001; Kragol et al., 2001;
Park et al., 1998).
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The cytotoxic activity and basis of specificity of cationic and amphiphilic peptides
has been best studied in bacteria. This specificity for bacteria over mammalian cells is
most likely related to fundamental differences between the two membrane types:
bacteria have a large proportion of negatively charged phospholipid headgroups on their
surface while the outer leaflet of animal cells is composed mainly of neutral lipids
(Zasloff, 2002). Also, the presence of cholesterol in the animal cell membrane appears
to reduce the HDP activity. The bactericidal activity of these peptides is very rapid,
occurring within minutes after exposure of bacteria to lethal doses of peptide. Several
mechanisms have been proposed for the process of cell killing (Christensen et al., 1988;
Ludtke et al., 1995; Matsuzaki et al., 1995, 1996; Pouny et al., 1992). It appears that
HDPs bind to the membrane surface in a non-cooperative fashion and then aggregate
once a threshold concentration is reached causing membrane permeabilization.
Membrane permeabilization is associated with a variety of other events including
membrane depolarization, leakage of cellular metabolites, loss of compositional integrity
due to enhanced membrane flip-flopping and translocation of peptides to the cytoplasm
where additional targets, such as RNA, DNA, and various enzymes, can be encountered
(Scott et al., 2008). It is unclear which of these events are primarily responsible for
bacterial killing and multiple hit models have been proposed with the exact mechanism
being dependent on the peptide and bacterium in question (Patrzykat et al., 2002).
Nevertheless, HDPs have remained an effective weapon against bacterial infection over
evolutionary time indicating that their mechanism of action thwarts bacterial responses,
which normally lead to resistance against toxic substances. This premise is supported by
data showing that no appreciable resistance to the action of the HDPs occurs after
multiple serial passages of bacteria in the presence of sub-lethal concentrations of the
peptides (Ge et al., 1999; Mosca et al., 2000; Tew et al., 2002).
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Mature Platelet Factor 4/CXCL4, a member of the CXC chemokine family, is a 70
amino acid protein with an N-terminal cytokine domain, a central domain responsible for
tetramerization, and a C-terminal domain that binds heparin and also can act as an HDP
(Yeaman et al., 2007). PF4 was the first characterized chemokine (Brandt et al., 2000),
though unlike other chemokines, PF4 does not have strong chemotactic properties and
does not interact with common chemokine receptors except human CXCR3B, an
alternatively-spliced CXCR3 (Lasagni et al., 2003). PF4 is a cationic tetrameric molecule
with high affinity for heparin and other large, negatively-charged molecules (Loscalzo et
al., 1985). Upon platelet activation, PF4 is released from platelet alpha-granules in high
local concentrations, up to 100 µM proximal to a clot (Lambert et al., 2007b). It is
important to note that PF4 has been implicated in both inflammation (Scheuerer et al.,
2000; Srivastava et al., 2008) and thrombosis (Eslin et al., 2004b). The Poncz lab has
shown that PF4 released from activated platelets forms complexes with endogenous
GAGs on the surface of platelets (Rauova et al., 2006) and monocytes (Rauova et al.,
2006) and likely on other hematopoietic and vascular cells. Mice that are knockout for
the cxcl4 gene (Eslin et al., 2004b) (deficient in PF4 (PF4 KO)) or overexpress hPF4
(hPF4+) have proven to be important tools in understanding in vivo PF4 biology during
thrombosis and megakaryopoiesis (Koenen et al., 2009; Lambert et al., 2007a).
Recently, Srivastava et al. have shown that PF4 mediates increased
inflammation in a mouse model of experimental cerebral malaria (Srivastava et al.,
2008), which they posit may occur through the chemokine domain of PF4. It is unclear if
these observations are clinically relevant to cerebral malaria in humans, given that this
murine model (P. berghei ANKA) is complicated by severe inflammation in the brain and
CNS, unlike human cerebral malaria in which little, if any, inflammation is seen
(Bruzzone et al., 2009; Haldar et al., 2007; White et al., 2009). As human cerebral
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malaria is a consequence of intravascular sequestration of infected erythrocytes in the
brain vessels and capillaries, rather than increased inflammation, it is unlikely that PF4
mediates increased inflammation during this disease process. Murine models of cerebral
malaria are further complicated by the marked accumulation of leukocytes and platelets
in the brain venules and capillaries, a phenomenon not seen in human pathology (White
et al., 2009). Given our preliminary in vitro and in vivo data implicating PF4 in
Plasmodium killing, utilizing P. falciparum in culture and a murine model that mimics
systemic anemia during severe infections (P. yoelli), we hypothesize that in fact the HDP
domain of PF4 serves as a natural human antimalarial and may offer insight into
development of novel therapeutics with little propensity for generation of resistance.
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II. MATERIALS AND METHODS
Reagents. Monoclonal antibodies against calpain-1 and Band 3 were purchased from Sigma.
Spectrin antibodies (α, β and β C-terminal domain) were donated by Dr. David Speicher (Wistar
Institute, Philadelphia), Band 4.9 antibody was purchased from BD Biosciences and all the other
antibodies (α-Adducin, Ankyrin-1, Flotillin-1, Stomatin, Actin, and CD47) were purchased from
Santa Cruz Biotechnology. Calpastatin was purchased from EMD Biosciences. Recombinant
human calpain-1 was purchased from Calbiochem. DCG04 was synthesized as reported
previously (Greenbaum et al 2000). Streptavidin-HRP was purchased from Vector Labs, and
Fura-2-Dextran and SYTOX Green from Invitrogen. Purified human calpain-1 was purchased
from Sigma, and calpastatin domain I from EMD Chemicals. Commercially available antibodies
were obtained from the following sources: anti-OXGR1, anti-GPR91, and anti-TRPC6 from
Abcam; anti-ankyrin-1, anti-GAPDH, anti-calmodulin 1, anti-calmodulin 2, anti-CAMKI, antiCAMKII, anti-PKAcat, anti-PLCb, anti-PLCg from Santa Cruz; anti-PKCa and anti-PKCb from Cell
Signaling. Anti-α- and β-spectrin antibodies were kindly provided by D. Speicher (Wistar Institute,
USA).

Growth and maintenance of P. falciparum cultures. Strain 3D7 Plasmodium parasites were
cultured in human erythrocytes (4% hematocrit) under standard conditions (37°C,
5%O2/5%CO2/90%N2) in RPMI buffer supplemented with HEPES and hypoxanthine. Replication
was tightly synchronized via serial treatments with D-sorbitol to lyse trophozoite- and schizontinfected erythrocytes. The remaining ring-stage parasites were cultivated to yield schizonts (~42
hr post-infection), which were selectively purified using a Miltenyi Biotec magnetic separator.
Cultures were staged by microscopy of Giemsa-stained blood smears and flow cytometry using
SYTOX Green (Life Technologies) as a marker of DNA content. Cultures were fixed with 4%
paraformaldehyde/0.0016% gluteraldehyde for 1 hour and permeabilized with 0.1% Triton X-100
for 10 minutes at room temperature prior to incubation with 5 µM SYTOX Green for 10 minutes
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and analysis on an Accuri Flow Cytometer.

Growth and maintenance of T. gondii cultures. RH strain T. gondii tachyzoites, and parasite
lines constitutively expressing P30-GFP or P30-RFP were cultivated in confluent monolayers of
human foreskin fibroblasts, human U2OS cells, or human A549 cells. Cells were grown to
confluence in Dulbecco’s modified Eagle’s medium containing 10% fetal bovine serum and
replaced upon infection with minimal essential medium containing 10% dialyzed fetal bovine
serum.

Preparation of erythrocyte membrane/cytoskeletal fractions. To prepare the infected
erythrocyte membrane, schizont-stage infected erythrocytes (∼35-40 hpi) were purified using a
magnetic column (Miltenyi Biotec). The parasites were then treated with 0.02% saponin in PBS
for 10 min at 4°C and centrifuged at 1,500xg. The supernatant was centrifuged again at 4,000xg.
This supernatant containing infected erythrocyte and parasitophorous vacuole (PV) contents was
then

ultracentrifuged

(200,000xg

for

2

hour

at

4°C)

to

collect

membranes.

The

membrane/cytoskeletal pellet was washed three times with PBS and subjected to a delipidation
procedure by ethanol extraction (Pasini et al., 2006) for 90 min prior to freezing with protease
0

inhibitors (Roche) at -80 C. Finally, uninfected erythrocyte membranes were prepared as
mentioned previously (Pasini et al., 2006). Erythrocytes were washed twice with phosphate
buffered saline (PBS) and subjected to hypotonic lysis in 5 mM lysis buffer (5 mM K2HPO4, pH
8.0) containing protease inhibitors for 10 min in ice. Ghost membranes were collected by
centrifugation of the lysate (200,000xg for 2 hour at 4°C). The pellet fraction containing the
erythrocyte membrane was washed until pellet appeared as yellow/white ghosts. After
delipidation, the membrane samples were frozen until used.
Purification and microscopic analysis of the erythrocyte-derived vesicles formed during
rupture. Schizont-stage parasites ~40 hours post invasion (hpi) were purified from synchronous
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cultures using a SuperMacs magnet (Miltenyi Biotech) and resuspended in culture medium. Once
the majority of schizonts ruptured, as determined by Giemsa smears, the culture media was
treated with protease inhibitor cocktail and further collected by centrifugation at 1,500xg for 10
min to remove residual uninfected and infected erythrocytes. This was followed by centrifugation
at 5000xg for 30 min to remove extracellular merozoites. Erythrocyte membrane material,
including small vesicles and loose membranes, resulting from rupture of parasites from
erythrocytes was then purified from the residual media by ultracentrifugation (L8-70M
ultracentrifuge, Beckmann) at 200,000xg for 2 hour at 4°C. The resulting erythrocyte membrane
material was then washed three times with PBS. The post-rupture erythrocyte vesicles isolated
were stained with FM4-64 (Invitrogen) and DAPI for DNA. Samples were analyzed using a
fluorescent microscope (Carl Zeiss Axioskop). Composite images were produced using
Photoshop 6.0.1.
Protein separation for mass spectrometry (MS). Aliquots from uninfected, infected
erythrocytes and post-ruptured vesicle membranes (∼100 µg from each sample) were solubilized
in Laemmli buffer under reducing conditions. After resolving on a 4-16% pre-cast gradient gel
(BioRad), polypeptides were stained with colloidal Coomassie. For mass spectrometric purposes,
gel slices of 0.5 cm were excised from the entire length of the gel for each sample (total of 34
slices). Gel slices were de-stained with 20 mM ammonium bicarbonate and dried in 100 %
acetonitrile. Tryptic peptides from each gel slice were dried on a vacuum evaporator for mass
spectrometry.
Mass Spectrometry. These studies were completed by Angela Wehr, Ph.D. Tryptic peptides
were resuspended in acetonitrile/water. Peptides were separated by reverse phase using an
Agilent 300 Extend-C18 column (3.5mm, 2.1 x 150mm). After a 6 min isocratic hold at 100%
mobile phase A linear gradient was run over the next 33 minutes increasing the percent B (0.1%
formic acid, 95% acetonitrile) to 60% all at a flow rate of 150 mL/min. Peptides were eluted online
to a ThermoFinnigan LTQ mass spectrometer (ThermoFisher, San Jose, CA) and were ionized
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using ESI in the positive mode. Nitrogen was used as the sheath gas and collision induced
disassociation (CID) experiments employed helium. Data dependent scanning was used to
identify the top five most abundant ions over the range m/z 400-1500. Each of the five most
abundant ions was then subjected to product ion scanning. (A mass tolerance of 2.0 Da for
precursor ions and 1.0 Da for fragment ions was permitted). We used the extract_msn.exe tool
from BioWorks version 2.x for generating peak lists from individual spectra.
Processing of Mass Spectrometry Data. These studies were completed by Angel Pizzarro,
Ph.D. at the Institute for Translational Medicine and Therapeutics at the University of
Pennsylvania. The raw MS/MS data were searched through SEQUEST (TurboSEQUEST - PVM
Slave v.27 (rev. 12), (c) 1998-2005) (Thermo Electron, San Jose, CA) against either a human
RefSeq database (NCBI version updated 11/19/07) or the Plasmodium database (plasmodb.org).
The databases were indexed using strict trypsin cleavage rules (K and R) with two maximum
internal cleavage sites. Carbamidomethylation of cysteine residues (fixed modification) and
oxidation of methionine (variable modification) were pre-set for the database searches.

The

SEQUEST output files were analyzed and validated by PeptideProphet (Version 3.0) as an
automated method to assign peptides to MS/MS spectra.

Post-analysis of the data was

performed using the Trans Proteomic Pipeline (TPP) with a peptide identification probability cutoff
of 0.05, which for all data sets corresponded to a FDR < 3%, and was < 2% for most data sets.
Data was further filtered and proteins with at least three peptides identified by SEQUEST were
considered as positive ‘hits’. Multiple biological experiments were carried out to reproduce and
confirm the proteomic results. GeneSpring Version 11.5 (Agilent) was used for generating heat
map from the information obtained from MS analysis to analyze the relative distribution of
proteins in gel slices among the three proteomes.

Immunodepletion and loading of erythrocytes. Erythrocyte ghosts were prepared by hypotonic
lysis as previously described utilizing 5 mM K2HPO4 at <4°C for 15 minutes (Chandramohanadas,
et al 2009). To immunodeplete target proteins, target antibodies were pre-conjugated to Protein
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G-Sepharose (Upstate/Millipore) following a titration to achieve maximal immunodepletion (1-10
6

µg antibody per 10 erythrocytes). Conjugates were incubated with ghosts for 3 hours on ice with
gentle mixing and repeated with fresh antibody-sepharose conjugates up to 3 times. The slurry
was separated by centrifugation and followed by another round of immunodepletion for cells
immunodepleted of multiple proteins. Ghosts were resealed by gradual addition of 5X resealing
buffer (475 mM KOAc, 25 mM Na2HPO4, 25 mM MgCl2, 237.5 mM KCl, pH 7.5) over 1 hr at
37°C. Parallel studies were carried out using anti-PKAcat, and mock treated erythrocytes were
incubated with Sepharose G beads without antibodies.

Analysis of host protein function during parasite exit from immunodepleted erythrocytes.
Resealed erythrocytes were prepared as described above. Schizont stages were isolated from 50
ml parasite culture by magnet purification ~40 hr after sorbitol synchronization, and added to
mock-treated, PKCa/b-depleted, PLCb1-depleted, calmodulin-1-depleted, Gaq-depleted, or
calpain-1-depleted erythrocytes to a final hematocrit of 4%. Parasite progress through the
intraerythrocytic cycle was monitored by Giemsa smear. Schizont-stage parasites were followed
to assess egress and the establishment of rings in newly-infected erythrocytes from 45-60 hpi.
6

Flow cytometry was used for quantitative evaluation of P. falciparum development. 10 events
were collected per sample using an Accuri flow cytometer and analyzed using Accuri software,
gating to exclude debris defined by scatter characteristics, and uninfected erythrocytes based on
low fluorescence; rings and trophozoites were distinguished from schizonts based on DNA
content. Data are presented as mean ± SEM; n=4.

Mechanical removal of P. falciparum from erythrocytes. Needle-shearing experiments were
completed as previously described (Dvorin, et al 2010) with modifications. Parasites trapped
within erythrocytes immunodepleted of calpain-1, PKCa/PKCb, PLCb1, or CaM-1, or negative
control Mock-immunodepleted or PKAa/bcat-immunodepleted erythrocytes, were plated in
quadruplicate. At the indicated timepoint, cultures were sheared by 20 strokes through a 28.5
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gauge needle. Cultures were incubated for an additional 12 h and ring stage parasitemia
determined by Giemsa smear microscopy and flow cytometry of DNA content. Data are
presented as mean ± SEM; n=4.
Monitoring calpain activation and membrane binding. Immunodepleted cells were prepared
as above and challenged with synchronous, magnet-purified schizont stage parasites. Following
48-hour incubation, infected cells were incubated with DCG04 (5 µM) and membrane fractions
were prepared from each sample by ultracentrifugation (2 h at 200,000xg). Equal amounts of
solubilized protein from each sample was separated by SDS-PAGE, transferred to PVDF
membrane, and probed for biotin using streptavidin-HRP, revealing DCG04 labeling of active
calpain. As a loading control, the same western blots were probed with actin antibodies (Santa
Cruz).

Erythrocyte membrane proteolysis in vitro by calpain-1. Aliquots of 10 µl (1µg/ µl) erythrocyte
membrane preparations were treated with 100 ng of purified calpain-1 in reaction buffer (20 mM
HEPES, 10 mM DTT & 5 mM CaCl2) for 30 min at 37°C. Negative controls were included by preincubating erythrocyte membranes with calpastatin or EGTA prior to the addition of activated
calpain. Samples were solubilized in Laemmli buffer under reducing conditions and resolved via
SDS-PAGE and visualized by colloidal Coomassie. A fraction from each reaction was also
resolved on SDS-PAGE, transferred to PVDF membrane and probed for α- and β-Spectrins,
Ankyrin-1, Stomatin, and Flotillin using commercially available antibodies.
Western Blot Analyses. Protein samples were solubilized in Laemmli buffer, separated by SDSPAGE and transferred to PVDF membranes. Membranes were probed using available antibodies
and visualized with corresponding secondary antibodies conjugated to HRP (Pierce). Hypotonic
lysis and resealing of erythrocytes with calpastatin was done as previously published [15].
Proteomic Protein Profiling. These studies were completed in collaboration with Rajesh
Chandramohanadas, Ph.D. Protein degradation was assessed by creating “chromatograms”
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where the number of peptides identified for each protein was plotted against the corresponding
gel slice where it was identified (as an approximation of molecular weight) from uninfected,
infected and post-rupture erythrocyte membrane proteomes. Majority of proteins peaked in gel
slices that roughly corresponded to the nominal molecular weight among the three proteomes.
Appearance of “peptide peaks” in lower molecular weight areas of the gel in the post-rupture
proteome and a corresponding absence or lessening of this peak in both uninfected and infected
samples suggested protein degradation in the former sample. To further evaluate protein
processing, peptides identified from proteolytic fragments were aligned manually against peptides
identified from the full-length protein (identified at the correct molecular weight area of the gel), for
several proteins that were found processed using chromatograms.
Immunofluorescence studies. Synchronous P. falciparum-infected erythrocytes or P30GFP/P30-RFP T. gondii-infected U2OS cells were fixed for 1 hour at RT with 4%
paraformaldehyde/0.008% gluteraldehyde, washed three times with PBS, permeabilized using
0.1% Triton X-100 for 10 minutes at 37°C, and blocked using 5% milk in PBS for 1 hour at RT.
Cells were incubated with primary antibodies to adducin-1 (Santa Cruz) in 5% milk in PBS
overnight at 4°C, washed three times with PBS, and incubated with secondary antibodies
preconjugated to Alexa-568, Alexa-Cy3, or Alexa-488 (Life Technologies) for two hours at RT.
Cells were washed three times prior to incubation with Hoechst DNA stain and imaging on a
Leica DMI6000B epifluorescent scope.

Monitoring T. gondii tachyzoite invasive capacity following block in host cell cytolysis.
Utilizing a T. gondii RH parasite line that expresses firefly luciferase, infected cells were
mechanically disrupted via scraping and filtration to remove host cell material at specified time
points following tachyzoite arrest within A549 host cells (beginning at 40 hpi) expressing
S716A/S726A mutant adducin. Parasites were then allowed to invade confluent monolayers of
HFF cells in 96-well plate format and assessed for viability 12 hours later utilizing the Luciferase
Reporter Assay Kit (Biovision) according to manufacturer’s instructions. Parasite viability was
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assessed relative to that of tachyzoites that originally infected wild-type A549 cells prior to
mechanical release. Data shown are means of at least 3 separate experiments +/- SEM.

siRNA Screen and shRNA stable knockdown generation. Primary siRNA oligos were
purchased from Santa Cruz, oligos for follow up screens were purchased from Ambion. siRNAs
were added at a final concentration of 20 nM in 96-well plates and titrated to achieve maximal
6

knockdown by 72 hours post-transfection, along with 10 U2OS cells in culture medium lacking
phenol red. Reverse transfection was carried out using Lipofectamine 2000 (Invitrogen) according
5

to the manufacturer’s instructions. Transfected host cells were inoculated with 10 P30-GFPexpressing T. gondii tachyzoites 24 hr post-transfection, and followed throughout the intracellular
cycle to assess invasion, replication, and egress rates at 6, 24, 44, and 60 hpi. Data are
presented in Figure 1B and C as mean number of unruptured vacuoles at 60 hpi versus 44 hpi ±
SEM; n=4. siRNA knockdown was confirmed via western blot of mirrored cultures utilizing
validated antibodies from Santa Cruz. Stable knockdown cell lines were generated following
transfection with huSH shRNA plasmids (Origene) encoding target shRNAs conjugated to soluble
cytoplasmic RFP to affirm knockdown and selection with puromycin (1 µg/ml) for 2 passages,
prior to isolation of clonal populations. Double knockdown cells were generated utilizing pGFP-BRS expression vectors (Origene) and selection with blasticidin. Following confirmation of
knockdown via western blot, cells were cultured in the absence of selection pressure.

T. gondii invasion, replication, and egress in knockdown cultures. Intracellular parasite
growth was measured by counting the number of parasites per parasitophorous vacuole at 6, 24
and 44 hr post-infection (prior to egress from the initial host cell). Confluent monolayers of ~5 x
5

6

10 stable knockdown host cells in 60 mm dishes were infected with 10 T. gondii parasites. At
least 100 vacuoles were counted per time point. Data are presented as mean ± SEM; n=5.

Monitoring T. gondii egress upon treatment with TCA metabolites. P30-GFP T. gondii
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tachyzoites were incubated in quadruplicate with confluent monolayers of HFF cells within glassbottom 35 mm dishes and allowed to undergo 3 parasite divisions (8 tachyzoite per PV stage)
prior to the addition of 50 µM lactate, aKG, or succinate, or a mixture of αKG and succinate, or
the Ca

2+

ionophore A23187 (10 µM) as a positive control of egress induction, to the culture

media. Dishes were followed by fluorescent microscopy within an environmental chamber that
mimics incubator conditions (37 degrees C, 5% CO2) until parasite egress.

P. yoelii 17XNL and P. berghei ANKA mouse studies. These experiments were conducted
with the assistance of Satish Mishra, Ph.D. in the laboratory of Photini Sinnis, M.D. at the Malaria
Research Institute, Bloomberg School of Public Health, Johns Hopkins University.
5

Swiss Webster mice were infected with 2x10 P. yoelii 17XNL parasitized erythrocytes in
200 µL of RPMI medium via intravenous injection. Following a standard 4-day Peters suppression
test protocol (Knight and Peters, 1980), the treatment regimen began on day 1 (the same day the
mice were infected) and mice were dosed once per day intravenously on days 1-3 with vehicle
(20% DMA in saline [n=3] or 20% Kleptose HPB [n=2]); 10 mg/kg mPF4 (in saline [n=3], R&D
systems); or 10 mg/kg C12 (in saline [n=4]). Parasitemias were determined on day 4 via Giemsastained blood smears.
4

C57BL/6 mice were infected with 2.5x10 P. berghei ANKA parasitized erythrocytes via
intravenous injection. Mice were dosed once per day intravenously on days 1-4 with either 5
mg/kg PMX1207 (in 20% DMA in saline [n=5]); 20 mg/kg PMX207 (in 20% Kleptose HPB [n=5]);
or untreated (Control, n=5). Parasitemias were determined on days 5 and 7 via Giemsa-stained
blood smears.

T. gondii mouse studies. These studies were completed by Christopher D. Dupont in the
laboratory of Christopher A. Hunter, Ph.D. at the School of Veterinary Medicine, University of
Pennsylvania. Age-matched female Swiss Webster mice were infected intraperitoneally with 10

3

RH parasites engineered to express the model antigen Ovalbumin and the fluorescent protein
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Tomato (RH-OVA-Tom; John, et al. 2009). Treated mice were administered 10 mg/kg Go6976
daily beginning 1-hour post-infection.

Five days post-infection, mice were euthanized, and

parasite burden in the spleen and peritoneal cavity was determined by flow cytometry. Statistical
significance was determined using a two-tailed Mann-Whitney Test. Data shown are compiled
from three separate experiments. Experiments were performed at the University of Pennsylvania
(UPenn) School of Veterinary Medicine in accordance with the guidelines of the UPenn
Institutional Animal Care and Use Committees.
PECS were obtained by peritoneal lavage with 5 mls of PBS (GIBCO). Splenocytes were
obtained by mashing spleens against a 40 µm cell strainer (Biologix) and resuspending in
complete RPMI (RPMI 1640 (Mediatech), 10% fetal calf serum (GIBCO), 1X non-essential amino
acids (GIBCO), 1X Penicillin Streptomycin (GIBCO), 1X beta-2-mercaptoethanol (GIBCO)). Red
blood cells were lysed by resuspending in lysis buffer (0.846% NH4Cl (Sigma-Aldrich)). Cells
were suspended in flow cytometry buffer (PBS, 0.2% bovine serum antigen (Sigma-Aldrich), 2mM
EDTA (Invitrogen)) and analyzed using a FACSCanto (BD) or LSRII (BD) flow cytometer. Data
was analyzed using FlowJo 8.8.7 software (TreeStar) and Prism 4 software (GraphPad).
CaMKII studies. U2OS cells were fractionated using Triton X-100. The cytoskeletal fraction was
incubated with 100 nM recombinant rat CAMKII (NEB) in 1X NEBuffer for Protein Kinases
supplemented with 200 µM ATP, 1.2 µM calmodulin and 2 mM CaCl2 and incubated for 1 h at
37°C. 100 nM recombinant human calpain (Biovision) was added to the mixture and incubated for
30 min at 37°C prior to separation by SDS-PAGE, transfer to PVDF membrane, and probing for
a-spectrin (primary antibody gift from David Speicher) and anti-rabbit secondary antibodies
conjugated to HRP (Sigma).

Ca

2+

studies. Erythrocytes were hypotonically lysed and loaded with 50 µM fura2-dextran prior to

resealing and incubation with synchronous P. falciparum schizonts. Parasites infecting fura-2dextran-loaded erythrocytes were followed by fluorescent microscopy and plate-based
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2+

fluorometry throughout the life cycle to assess host erythrocyte cytoplasmic [Ca ] via the
2+

equation: [Ca ] = Kd Q (R-Rmin)/ Rmax-R), where R represents the fluorescence intensity ratio at
340 nm/380 nm excitation and emission at 510 nm. Data are presented as mean fluorescence ±
SEM; n=3. Representative images are shown.
U2OS cells were transduced using the Premo Cameleon Calcium Sensor (Life
Technologies) according to manufacturer’s instructions to facilitate cytoplasmic expression of
2+

YC3.6 prior to synchronous T. gondii infection. Host [Ca ] was measured throughout the parasite
life cycle via FRET microscopy on a Leica DMI6000B and FRET-based fluorometry to assess
2+

[Ca ] as a function of CFP/YFP emission ratio. Data are presented as mean fluorescence ±
SEM; n=3. Representative images are shown.

Assessing background (digestive vacuole) FRET-based or Fura-2 fluorescence. In order to
determine CKAR or Fura-2 signal that was attributable to uptake into the parasite digestive
vacuole, sorbitol-synchronized 3D7-CKAR parasites or 3D7 parasites infecting erythrocytes
loaded with Fura-2 dextran were selectively removed from their host cells using 0.1% saponin in
PBS at 3 hour increments throughout the intracellular cycle, washed, and plated in quadruplicate
prior to assessment of plate-based fluorescence as described in the main experimental
procedures. Representative images were also taken on a Leica DMI6000B epifluorescent
microscopy. Data are presented as mean +/- SEM; n=4.

CKAR transfection and PKC activity measurement. CKAR plasmid (Addgene) was transfected
into U2OS cells using Lipofectamine 2000 (Life Technologies) according to manufacturer’s
instructions. 3D7-CKAR construct was generated via addition of a minimal export PEXEL motif Nterminal to CKAR (Marti, et al 2004; Hiller, et al 2004) following PCR amplification from the CKAR
plasmid. This was achieved via amplification of the N-terminus of the exported protein KAHRP
(PF3D7_0202000) from cDNA of asynchronous 3D7 parasite cultures and recombination with the
CKAR motif into the P. falciparum expression vector p-HHVPatt using MultiSite Gateway (Marti et
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al., 2004). Constructs were transfected into the P. falciparum 3D7 line and selected using 10 nM
WR99210 (an inhibitor of dihydrofolate reductase; Fidock and Wellems, 1997). 3D7-CKAR
transgenic parasites and T. gondii-infected U2OS cells expressing CKAR were cultured under
standard conditions and assessed for PKC activity via FRET-based fluorometry as a function of
YFP/CFP emission ratio and FRET imaging on a Leica DMI6000B. Data are presented as mean
± SEM; n=4. Representative images are shown.

Parasite IC50 determination. These studies were completed in collaboration with Melissa S.
Love at the University of Pennsylvania.

Compounds were assayed for 72h, after which the

cultures were fixed with a solution of 4% paraformaldehyde and 0.008% glutaraldehyde in PBS
prior to permeabilization with 0.25% Triton X-100, and 5 µM SYTOX Green Nucleic Acid Stain
and flow cytometry analysis (Accuri C6 Flow Cytometer with C-Sampler). IC50 curves were
generated using GraphPad Prism.

Hemolysis. These studies were completed by Melissa S. Love at the University of Pennsylvania.
Following removal of culture supernatant before fixing and transferring to a clear-bottom plate.
Absorbance at 541 nm was measured and compared to a standard curve generated from Triton
X-100-lysed erythrocytes.

Platelet activation. Platelets were collected from C57BL/6 mice (WT), homozygous PF4
knockout mice (PF4 KO), and transgenic mice overexpressing human PF4 (hPF4+) (Eslin et al.,
2004a) and added to cultures either with or without pre-activation ex vivo with 5 µM AYP.
Parasitemia was assessed via flow cytometry after 24 hours treatment.

Parasite membrane potential assays. These studies were completed in collaboration with
Melissa S. Love at the University of Pennsylvania. Parasite-infected erythrocytes were incubated
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at 37°C for 30 minutes with 1 µM rhodamine 123 (for parasite plasma membrane potential), 0.2
µM rhodamine 123 (for parasite mitochondrial potential) (del Pilar Crespo et al., 2008), or 10 nM
LysoTracker Red (for digestive vacuole potential). After pre-incubation, parasites were treated for
4 hours with the test compound, a 10 µM mixture of the ionophores monensin (Sigma) and
nigericin (Calbiochem) as a positive control of membrane potential perturbation, or left untreated
and then analyzed via fluorescence microscopy on a Leica DMI6000 B.

Fluorescence microscopy and quantification of digestive vacuole lysis. Erythrocytes
infected with synchronous cultures of PMII-GFP expressing parasites were treated at 30 hours
post invasion (hpi) and fixed at the indicated time points, stained with Hoechst and imaged by
fluorescence microscopy. Cells were also analyzed on an Amnis ImageStream X high-resolution
flow cytometer with gating for Hoechst-positive cells to isolate infected cells (Muskavitch et al.,
2008; Ortyn et al., 2007).

smHDP screen. These studies were completed in collaboration with Melissa S. Love at the
University of Pennsylvania. Synchronized parasites were treated with 500 nM of each smHDP for
72 hours. Cells were then fixed and assayed for parasitemia via flow cytometry. Compounds were
deemed hits if they caused ≥80% parasite death, as compared to a 500 nM chloroquine-treated

positive control. The Z-factor was calculated using the equation

Z' = 1 !

3(

p
p!

+

n
n

)

where µ

represents the means and σ represents the standard deviations of the positive (p) or negative (n)
controls (Zhang et al., 1999).

!

HDP screen and assay for hemolysis. These studies were completed by Melissa S. Love at the
University of Pennsylvania.

P. falciparum parasites (3D7 strain) were cultured as described

previously. Synchronized parasites were treated with 15 µM of 9 platelet-, neutrophil-, or
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lymphocyte-derived proteins containing HDP-domains or properties: Regulated upon Activation,
Normal T-cell Expressed, and Secreted (RANTES, ProSpec); Platelet Factor-4 (PF4,
Haematologic Technologies Inc.); Fibrinopeptide-A (FP-A, AnaSpec); Fibrinopeptide-B (FP-B,
AnaSpec); Human Neutrophil Peptide-1 (HNP-1, AnaSpec); Human Neutrophil Peptide-2 (HNP-2,
AnaSpec); Cathelicidin (LL-37, AnaSpec); Lymphotactin (ProSpec); Lactoferrin (ProSpec). 15 µM
melittin, the major active component of bee venom, was used as a positive control for HDP-killing
of parasites with complete hemolysis. Parasite death was normalized to a 500 nM artesunate
control. Parasites were treated for 72 hours, and then fixed and assayed for parasitemia via flow
cytometry. Hemolysis was measured by removing 50 µL from each well (100 µL total in a 96-well
plate) before fixing and transferring to a clear-bottom plate. Absorbance at 541 nm was measured
and compared to a standard curve generated from Triton X-100-lysed erythrocytes (4%
hematocrit serially diluted by 2).

Fluorescence microscopy of PMX496. Erythrocytes infected with synchronous cultures of wild
type parasites (3D7) were treated at 30 hpi with 250 nM of the intrinsically fluorescent PMX496
(green: PMX496, blue: parasite nuclei) and followed at specified time points on a Leica DMI6000
B.

Protamine sulfate studies. hPF4 immunofluorescence was assayed as described above with
pretreatment of cultures with 5 mM protamine sulfate or mock (DMSO) for 30 min prior to hPF4
treatment.

Western blot analysis of PF4 accumulation. Synchronous cultures of P. falciparum-infected
erythrocytes were treated with 10 µM PF4 then 0.1% saponin to separate erythrocyte fractions
from parasite material. Samples were run by standard SDS-PAGE, transferred to Immobilon
Transfer PVDF membrane and incubated with 1:1000 primary antibody to human PF4 and
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1:10000 anti-mouse secondary antibody. Input of total cell lysates was used as a loading control,
using a primary antibody to flotillin and an anti-rabbit secondary antibody.

Transmission Electron Microscopy. Synchronous cultures of P. falciparum parasites were
magnet-purified at ~25 hpi and allowed to sit for 6 hours prior to a 10-min exposure to 10 µM
PF4, 500 nM PMX207 or PMX1207. DMSO was used as a negative control. Samples were frozen
in an Abra high-pressure freezer. This material was freeze substituted in 2% OsO4 in anhydrous
acetone and embedded into Epon. Images were collected at 120KeV on a FEI Tecnai12
equipped with a Gatan 894 2k camera. Images were captured by Dewight R. Williams, Ph.D. at
the Electron Microscopy Core at the University of Pennsylvania. Tilt series were taken +/- 70° in
3° increments at 6500x magnification. Tilt images were decimated by a factor of 2 and initially
aligned by cross-correlation in FEI’s inspect3D. Tomograms were constructed from fiducially
aligned stacks, orthogonal merged axes, and subsequent serial tomograms joined in the IMOD
package “etomo”. Montage images taken with 10x10 sampling at 3200x magnification were
aligned with blendmont.

Texas Red Dextran-loaded erythrocyte analysis of DV lysis. Erythrocytes were lysed and
resealed as described previously in the presence of 10 µM Texas Red Dextran prior to challenge
with synchronous magnet-purified cultures of P. falciparum-schizont stage parasites. Infected
erythrocytes containing Texas Red Dextran were treated at 30 hpi with hPF4, C12, or smHDPs
as previously described and imaged on a Leica DMI6000B epifluorescent microscope to assess
lysis of the parasite DV, denoted by Texas Red Dextran dispersion throughout the parasite body.
Infected Texas Red Dexran-loaded cells were also subjected to gametocytogenesis as previously
described (Fivelman et al., 2007) and treated with hPF4 or PMX1207 at stage 2 prior to
fluorescent microscopy analysis of DV lysis.
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Statistical analyses. Statistical significance of unruptured vacuole persistence, in vitro
parasitemias, FRET-based signal for CKAR activity or YC3.6 Ca

2+

studies, and Fura-2 signal with

a one-way ANOVA with Dunnett’s post-hoc test. In vivo mouse parasitemias were analyzed with
one-tailed paired Student’s t-tests and mouse survival was analyzed using the Mantel-Cox logrank test.
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III. Progressive dismantling of the host cytoskeleton facilitates
Apicomplexan parasite exit:
Targeting host protease activity for death by entrapment
	
  
We employed a proteomic approach to understand the molecular basis for the large
changes in the infected erythrocyte cytoskeleton upon schizont maturation and egress.
Three proteomes were compared via mass spectrometry-based analysis: (i) the plasma
membrane proteome from uninfected erythrocytes, (ii) the erythrocyte/PV membrane
proteome from infected erythrocytes prior to parasite egress (~40 hpi, 8 hours prior to
egress), and (iii) the erythrocyte/PV membrane proteome isolated from infected
erythrocyte post-rupture vesicles. Although there certainly could be important cytosolic
protein modifications during parasite egress, changes in the soluble proteome were
largely obscured by hemoglobin, thus we specifically analyzed proteins in only the
membrane fractions.
Proteomic analysis of changes to the host membrane proteome during parasite
egress
We developed a differential fractionation strategy to isolate these three host
membrane proteomes (Figure 1A). Uninfected erythrocyte membranes were isolated by
hypotonic lysis followed by ultracentrifugation. To isolate extraparasitic membranes
(PV/erythrocyte) from infected erythrocytes, magnet-purified schizonts were separated
from uninfected erythrocytes (Greenbaum et al., 2002), then treated with saponin, which
at low concentrations (0.02%) selectively permeabilizes the erythrocyte/PV sparing the
parasite plasma membrane (Chandramohanadas et al., 2009). The erythrocyte/PV
membranes were then enriched by low speed centrifugation to remove whole parasite
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cells

and

further

isolated

by

ultracentrifugation

as

described

elsewhere

(Chandramohanadas et al., 2009). To isolate post-rupture vesicle membranes from
infected erythrocytes, highly synchronous cultures of late-stage infected erythrocytes
were magnet-purified and allowed to naturally egress in culture media. Extracellular
merozoites were then separated from culture media (containing post-rupture membrane
vesicles) by low speed centrifugation (1,500xg). Post-rupture membrane vesicles were
then isolated from the media by ultracentrifugation at 200,000xg for 2 hours. For
comparison, we show FM4-64 stained images of uninfected erythrocytes; parasite
culture media collected immediately after rupture that contains both intact uninfected
erythrocytes and post-rupture vesicles (red), as well as released merozoites stained with
Hoechst (blue); and purified post-rupture vesicles purified from the media after parasite
egress (red) (Figure 1B). We observed little parasite contamination in either the infected
erythrocyte membrane preparation or the samples enriched for post-rupture vesicles. To
confirm that we achieved purification of extraparasitic membrane material, we show the
enrichment of the erythrocyte membrane marker Band 4.9 and the concomitant loss of
GFP from a parasite line expressing cytosolic GFP (Figure 1C).
To identify and compare proteins from these three proteomes we employed an SDSPAGE/MS approach akin to the geLC-MS/MS approach used by the Mann group
(Shevchenko et al., 2006), where samples were first separated by one-dimensional SDS
PAGE, then individual gel slices across the entire lane were excised and subjected to
LC/MS/MS analysis. The uninfected, infected erythrocyte and post-rupture vesicle
membranes were first delipidated by incubating with sodium acetate/ethanol for 1 hour at
room temperature, which enhanced the recovery of peptides in the subsequent LC/MS
analysis (Pasini et al., 2006). The polypeptides were then separated by SDS-PAGE and
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stained with colloidal Coomassie. Initially we observed that the uninfected erythrocyte
and the infected erythrocyte membrane proteome migration pattern by Coomassie to be
comparable, apart from a major reduction in spectrin band intensity in the infected
erythrocyte membrane sample. However, the migration pattern for the post-rupture
vesicle membrane proteome was markedly different (Figure 2A).
Thirty-four individual gel slices were excised throughout the SDS-PAGE lanes in
order to identify proteins and assess their relative size for each of the three proteomes
(as graphically depicted in Figure 2A). Each excised gel band was digested with trypsin,
peptides were analyzed by LC/MS/MS and peptides were matched to proteins using
SEQUEST. A total of 33,386 entries from the NCBI database were searched for protein
identification. Proteins that had at least three peptides from a minimum of two
independent MS analyses were considered as confident ‘hits’. Most datasets had a false
discovery rate of < 2. Although the Coomassie stained gels only revealed a few major
proteins, we identified approximately 250 proteins from each sample (Figure 4B), which
is commensurate with prior proteomic studies of human erythrocytes (Pasini et al.,
2006);

thus most proteins were present at a level below the level of detection by

Coomassie. Furthermore, proteins identified were well distributed throughout the SDSPAGE gel (Figure 2B). Spectral counting analysis was used to compare the ratios of
total protein abundance, which revealed that only ~15% of the protein hits changed more
than 3-fold (first two bars in histogram), while the relative abundance of the remaining
~85% of proteins was within 3-fold (0.3-1 and 1-3) amongst all three proteome samples.
This data indicates that although the Coomassie stained gels showed different patternsprimarily due to huge losses of a few major erythrocyte membrane proteins such as
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spectrins, the abundance of the majority of infected erythrocyte membrane proteins
remained unchanged during parasite egress (Figure 2C).
Adducin is lost from the host cytoskeleton 10-15 hours prior to parasite egress
In comparing the proteomes of uninfected erythrocytes and infected erythrocytes, we
observed that a subset of host proteins identified with high confidence in the uninfected
membrane samples were absent or highly reduced (>>3 fold change) in both the
infected erythrocyte and post-rupture vesicle membranes (Table 1), suggesting that
major cytoskeletal modifications may be occurring far earlier in the erythrocytic life cycle.
We observed that erythrocyte adducins, tropomyosin and Rac1 disappear from the
membrane fraction around 35 hpi, which was striking as these proteins have been
shown to be important for the integrity of the cytoskeleton (Kalfa et al., 2006). Direct loss
of adducin via mutations or through the loss of Rac1/2 has been shown to disrupt
spectrin/actin junctions,(Kalfa et al., 2006) leading to spherocytosis and increased
hemolysis in in vivo mouse models (Gilligan et al., 1999; Robledo et al., 2008). Western
blot analysis of infected erythrocyte membrane fractions confirmed that a-adducin is
present through the first two-thirds of the intraerythocytic life cycle but is lost from the
host cytoskeleton at ~35 hpi (Figure 3A). These data was corroborated using
immunofluorescence, which showed that adducin is localized to the plasma membrane
of uninfected and early stage infected erythrocytes (up to 30 hpi), but disappeared
around 35 hpi (Figure 3B). Uninfected erythrocytes also showed an abundance of
cytoplasmic adducin staining, which is diminished in infected cells possibly due to
parasite digestion of host cytoplasm. We also show that adducin loss from the
cytoskeleton is not dependent on calpain, as calpastatin loading into hypotonically lysed
and resealed erythrocytes did not prevent adducin loss from the membrane fractions of
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infected erythrocytes by western blot analysis (Figure 3C). The loss of a-adducin, as
well as tropomyosin and Rac1 following schizogony suggests that cytoskeletal
dismantling in preparation for egress begins much earlier than previously thought.
Analysis of proteome changes reveals global proteolysis of the host cytoskeleton
during parasite egress
Considering the previously proposed role of proteases in parasite egress, we next
focused our analysis of the proteomic data on proteins that appeared to be proteolyzed
during egress. To do this, we searched for proteins that appeared at significantly smaller
sizes than expected in the post-rupture vesicle membrane proteome compared to the
infected erythrocyte and uninfected erythrocyte proteomes, as they likely represented
proteins proteolytically processed during parasite egress. We used several overlapping
methods to determine proteins that appeared smaller in size. Spectral counts for each
protein were plotted against their position in the actual gel lane to create
“chromatograms” representing their migration pattern in the SDS-PAGE gel (Figure 4A)
for each proteome, which provided a simple yet efficient tool to compare progressive
changes in protein distribution patterns between the three proteomes. Although
cytoskeletal proteins such as a-spectrin, ankyrin, actin, and band 4.1 were identified at
their expected molecular weight in the infected erythrocyte sample, these proteins were
also detected at lower molecular weight areas of the chromatogram in the post-rupture
vesicle membrane samples, suggesting that they had been proteolyzed. It is worth
noting that ankyrin had been previously shown to be proteolyzed by crude parasite
lysates (Raphael et al., 2000). However, the majority of proteins, such as flotillin-1 and 2, showed no apparent cleavage, as shown by the lack of any low-molecular weight
fragments (Figure 4A, top panel). This revealed that although several proteins from the
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post-rupture vesicle membrane proteome appeared smaller than their predicted size
(Figure 4A, lower panel), the majority of proteins did not undergo any proteolytic
cleavage during rupture and appeared at their expected molecular weight in all three
proteome samples.
Using this method, we estimated the number of proteolyzed proteins in all three
proteomes. We observed a doubling in the number of proteolyzed proteins (2% to 5%)
from uninfected to infected erythrocyte membrane proteome, however, the magnitude of
proteolysis was significantly increased in the post-rupture vesicle proteome (12%)
(Figure 4B). Proteins that had undergone proteolysis were then classified into functional
categories: the majority of these proteins (approximately 60%) were associated with or
members of the cytoskeleton (Figure 4C). To date, most of these cytoskeletal proteins
have not been reported to be proteolyzed in uninfected erythrocytes or during P.
falciparum infection.
To confirm our predictions, we conducted western blot analysis of potential
proteolyzed hits over a timecourse throughout the parasite life cycle (10-hour increments
from 10-40 hpi), in comparison to uninfected erythrocytes (U) and post-rupture vesicles
(R). Processing of several proteins at the time of rupture that were found to be
proteolyzed from the MS data were confirmed, including the key cytoskeletal proteins
α/β-spectrins and ankyrin-1 (Figure 5A), as fragments appeared in the post-rupture lane
that were similar in size to those found in the MS analysis (see Figure 4A). Several lipid
raft-associated proteins including the flotillins were protected from proteolysis, and
served as loading controls for the rest of the western blots shown in Figure 5A.
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We also identified the presence of several proteases in the infected erythrocyte
proteome (Table 2). Notable among these was host calpain-1 that was present only in
the late-stage infected erythrocyte membranes and post-rupture vesicle membranes.
Calpain-1 activation and its corresponding association with the erythrocyte membrane
are important for malaria parasite egress, as we described recently (Chandramohanadas
et al., 2009). We investigated whether calpain activity could account for the degradation
of much of the observed cytoskeletal proteolysis during parasite egress, via incubation
with erythrocyte membrane fractions in the presence of Ca2+ for 30 minutes. We provide
in vitro data validating that, indeed, activated calpain-1 can cleave a whole spectrum of
cytoskeletal proteins, generating fragments of similar size to those found in our MS and
western blot analyses of post-rupture vesicles (Figure 5B). In addition to calpain-1,
parasite-derived SERA proteins, which have been postulated to have a role in egress,
were abundantly found in our infected erythrocyte and post-rupture vesicle membrane
samples (Yeoh et al., 2007).
Discussion
Our proteomic data revealed that several host proteins, including most prominently
α/β-adducin, disappeared from the host erythrocyte cytoskeleton significantly prior to
parasite egress. Targeted disruption of adducin genes has been long known to result
increased fragility of the erythrocyte membrane that ultimately leads to spherocytosis
and increased hemolysis in mice (Chen et al., 2007; Gilligan et al., 1999; Robledo et al.,
2008). Thus this initial weakening of the cytoskeleton via the loss of the adducins
(perhaps the loss of tropomyosin and Rac1 as well) may be required for the later
destruction of membrane integrity to permit facile parasite escape. We determined that
α-adducin loss from the erythrocyte cytoskeleton is both temporally and mechanistically
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distinct from the changes enacted on the host cell at the time of egress by host calpain1. This suggests a new mechanism used by malaria parasites, occurring 15-20 hours
prior to parasite egress in order to prepare the infected erythrocyte for rupture. This
process may be mediated by parasite kinases to modify host proteins during egress
since phosphorylation of cytoskeletal proteins has been shown to result in progressive
changes to the cytoskeletal network (Lu et al., 1985; Manno et al., 1995; Soong et al.,
1987). Though parasite kinases have been shown to be exported into the host cell
(Nunes et al., 2007; Vaid et al., 2010), a direct link between parasite kinase activity and
infected erythrocyte cytoskeletal changes during egress has yet to be explored.
In addition to the loss of α-adducin, our proteomics data revealed that a significant
proportion of erythrocyte cytoskeletal proteins were proteolyzed upon parasite egress. In
fact, in post-rupture vesicle membranes, the total amount of spectrins diminished to
~10% of that found in uninfected erythrocyte membranes. In total, more than 60% of the
proteins that were found to be proteolyzed were associated with the host cytoskeleton
including most prominently the spectrins, ankyrin, and actin, suggesting that global and
pathological proteolysis of the host cytoskeleton occurs during the parasite egress
process (~48 hpi). Several proteases were also found associated with the infected
erythrocyte and post-rupture vesicle membranes, including host calpain-1, an essential
enzyme that apicomplexan parasites utilize for egress (Chandramohanadas et al.,
2009). We show that calpain-1 can proteolyze most cytoskeletal proteins during egress,
which likely accounts for the striking breakdown of the host erythrocyte membrane
around the parasite. Although calpain-1 is capable of proteolyzing many of the
cytoskeletal proteins, it is possible that other putative parasite proteases such as SERA
family proteases can also perform this function; importantly, SERA5/6 were found to be
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in abundance on infected erythrocyte membranes and post-rupture vesicles. Although
there is little data concerning the proteolytic activity of SERA proteins or for their direct
role during parasite egress from the erythrocyte, it is also possible that they contribute to
the egress process through destabilization of the host membrane via a non-proteolytic
role.

Table 1

Table 1. Proteins that are absent/reduced in infected erythrocyte and/or post-rupture vesicle
membranes. List of high abundance proteins that were identified in the uninfected erythrocyte membranes
and absent or reduced in the infected erythrocyte and post-rupture vesicle membrane samples.
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Table 2A. Proteases identified in the proteomic analyses from infected
erythrocyte membranes (I).

	
  

Table 2B. Proteases identified in the proteomic analyses from post-rupture
vesicle membranes (R).

Table 2. Proteases identified from infected erythrocyte and post-rupture vesicle membrane samples.
A list of proteases identified with four or more unique peptides from (A) infected and (B) post-rupture vesicle
membrane proteomes are listed.
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Figure 1. Fractionation strategy for comparing uninfected
erythrocyte, infected erythrocyte and post-rupture vesicle membrane
proteomes.

To understand the global changes in the erythrocyte membrane proteome upon parasite egress, parasiteinfected (I) and post-rupture vesicle membranes (R) were isolated and compared with uninfected erythrocyte
membranes (U). Newly replicated parasites (P) and the food vacuole following schizogony (FV) are also
shown. (A). Uninfected erythrocyte membranes were prepared by hypotonic lysis and ultracentrifugation.
The infected erythrocyte membrane proteome was prepared by saponin treatment of magnet-purified
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schizonts and ultracentrifugation. To prepare post-rupture vesicle membranes, we used a differential
centrifugation strategy to purify vesicles from media following parasite egress (see methods for more
details). All the samples were solubilized in Laemmli buffer, resolved by SDS-PAGE and visualized by
colloidal Coomassie staining. 34 slices were excised from each proteome for analysis by mass
spectrometry. (B). To illustrate the efficiency of the fractionation strategy, the purification of post-rupture
vesicles was visualized by microscopy. Each fraction was stained with FM4-64 for membrane staining and
DAPI for DNA. Panel 1: Uninfected erythrocytes; Panel 2: crude media just after parasite rupture from
infected erythrocytes containing merozoites (arrow marks), post-rupture vesicles (arrowheads) and intact
erythrocytes (broken line); Panel 3: purified post-rupture vesicles derived from parasite egress. (C).
Selective enrichment of infected erythrocyte membranes from parasite material was also confirmed by
western blot analysis using a transgenic parasite line expressing cytosolic GFP. Protein from whole infected
erythrocytes (I), purified parasite cells fractionated by low speed centrifugation from saponin-treated infected
erythrocytes (P), or post-rupture vesicles fractionated from media after parasite egress (R) were separated
by SDS-PAGE. Efficient isolation of infected erythrocyte membrane material was determined by western
using a parasite cytoplasmic marker (anti-GFP) and a human erythrocyte membrane marker (anti-Band 4.9).
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Figure 2. Comparative proteomic analysis of the erythrocyte
membrane proteome during parasite egress.

(A). Infected erythrocyte membranes (I) and post-rupture vesicles derived from parasite egress (R) were
isolated and compared with uninfected erythrocyte membranes (U). Samples for the proteomic analysis
were resolved on a 4-12% SDS-PAGE gel and stained with colloidal Coomassie. 34 slices were excised
from each sample lane, digested with trypsin, extracted, and analyzed by LC/MS/MS mass spectrometrybased sequencing. The overall migration pattern for the post-rupture vesicle membrane proteome was
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different, as the characteristic high molecular weight spectrin doublet appeared to be degraded and with the
appearance of more small molecular weight bands. (B). Peptides from each gel slice were sequenced by
mass spectrometry and the percentage distribution of identified proteins through the SDS-PAGE lanes for all
samples (U, I, and R) were expressed in a heat map format. Red color indicates high percentage of peptides
per protein (10%) while yellow indicates minimum (0%). This representation indicates that proteins were well
distributed throughout the SDS-PAGE gel. (C). Spectral counting was used to compare the relative
abundance of each protein from the three proteomes. The total number of peptides was summed for each
identified protein in the infected erythrocyte and post-rupture vesicle proteome samples and was individually
compared to the uninfected preparation to determine fold changes in relative protein abundance among the
three proteomes. The abundance of most proteins remained similar (within a 3-fold difference) among the
three proteomes, whereas a small proportion (~10%) showed markedly lower abundance in the post-rupture
vesicle proteome.
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(A). Western blot analysis confirmed the loss of adducin from the membrane fraction of infected erythrocytes by 35 hours post-invasion.
Flotillin levels are shown as a loading control. (B). Immunofluorescence confirms the presence of adducin in uninfected, ring, and
trophozoite infected erythrocytes, and its absence in schizont-infected erythrocytes. (C). Western blot analysis of calpastatin-loaded
infected erythrocytes confirms that the loss of adducin from the infected erythrocyte cytoskeleton around 35 hpi is calpain-independent.

Figure 3. Loss of adducin from the erythrocyte cytoskeleton prior to
parasite escape is calpain-independent.
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Figure 4. Proteomic profiling shows extensive cytoskeletal protein
proteolysis during parasite egress.

(A). To determine proteins that were proteolytically processed, the spectral count for each protein was
plotted against the corresponding gel slice number (and hence the apparent molecular weight) judged from
its migration in the SDS-PAGE gel. Several proteins appeared smaller than their expected molecular weight
as indicated by a second peak in the chromatogram corresponding to a lower molecular weight as seen in αspectrin, band 4.1 and actin. Abundance of the smaller species was universally increased in the post-rupture
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vesicle proteome sample. Otherwise, the majority of the proteins showed no major difference in abundance
and molecular weight as exemplified by flotillin-1. (B). Proteolysis of host membrane proteins significantly
increases at egress. Number of processed proteins identified from the uninfected (U), infected erythrocyte (I)
and post-rupture vesicle (R) membrane proteomes is expressed as a percentage of total proteins identified.
(C). Proteins that were processed in the post-rupture vesicle erythrocyte membrane were classified
according to their functions as obtained from the human proteins reference database (www.hprd.org), and
corresponding Gene Ontology (GO) annotation.
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Figure 5. Validation of calpain-dependent cytoskeletal processing
during parasite rupture.

(A). Western blot analysis from uninfected erythrocyte (U), infected erythrocyte throughout the life cycle (1040 hpi), and post-rupture vesicle (R) membranes was used to validate the proteolytic processing of
candidate proteins. Analysis of α-spectrin, β-spectrin and ankyrin-1 showed major degradation of target
proteins only in the post-rupture vesicle proteome sample whereas many proteins, such as flotillin (shown as
loading controls underneath each blot) showed no proteolytic processing. (B). Erythrocyte membranes
treated for 30 min with activated human calpain-1 were able to recapitulate the processing observed in postrupture vesicles. Western blot analysis of calpain-mediated processing is shown for α-spectrin, β-spectrin,
and ankyrin-1.
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We propose that parasite egress begins as early as 35 hpi with the loss of spectrin/actin adaptors, and lead to the formation of large holes
in the cytoskeleton mesh, followed by large-scale calpain-mediated proteolysis of the remaining cytoskeleton at 48 hpi to eventually
release merozoites.

Figure 6. New model for parasite driven modifications to the host
cytoskeleton during parasite egress.
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IV. Host GPCR signaling necessary for parasite-mediated cytolysis:
Thwarting host signaling to stop them in their tracks
Parasite-induced host cell cytolysis has been suggested to be a two-step, Ca2+dependent process (Salmon et al., 2001; Wickham et al., 2003b) requiring both host cell
ion loss (Moudy et al., 2001) and increased membrane poration (Abkarian et al., 2011;
Glushakova et al., 2010). Recent reports implicate the activity of parasite-derived
proteins including: a perforin-like protein (Kafsack et al., 2009), a kinase (Dvorin et al.,
2010), and proteases (Arastu-Kapur et al., 2008; Yeoh et al., 2007) though reports of
host protein contribution to this process are limited. We have recently shown that the
host-derived protease calpain is required for exit of both P. falciparum and T. gondii and
functions to proteolyze the actin cytoskeleton just prior to cytolysis (Chandramohanadas
et al., 2009; Millholland et al., 2011). Furthermore, we have identified calpainindependent loss of adducin from the host erythrocyte actin cytoskeleton prior to P.
falciparum exit (Millholland et al., 2011). Given the temporal separation of these striking
changes to the host cytoskeleton during the last phase of the intracellular cycle, we
hypothesized that a complex host pathway may connect these changes and result in the
disintegration of the host plasma membrane. Identification of host proteins necessary for
parasite infection may offer an untapped resource of antiparasitic targets.
Host RNAi screen reveals a pathway necessary for T. gondii-mediated cytolysis
To identify host genes essential for parasite-mediated cytolysis, we performed an
RNAi screen in U2OS cells (highly transfectable T. gondii host cells) focused on
canonical Ca2+-signaling components, given our earlier studies that implicated host
calpain in T. gondii and P. falciparum exit (Chandramohanadas et al., 2009, Millholland
et al., 2011). To circumvent the potential for functional redundancy between host gene
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isoforms, we tested pooled siRNAs for simultaneous knockdown of gene families, as
well as individual genes present in both U2OS cells and erythrocytes. This primary
screen included 45 individual gene knockdowns and 11 multi-isoform knockdowns
(Tables 3,4). Pooled siRNAs (three siRNAs/gene) were arrayed in quadruplicate,
reverse-transfected into U2OS cells, and infected 24 hours post-transfection with
transgenic T. gondii tachyzoites (MOI of 0.1) that constitutively secrete GFP into the PV
space, allowing for facile identification of parasite doublings as a function of life cycle
progression (P30-GFP; Figure 7A, Figure 8; (Striepen et al., 1998). siRNAs against
calpain small subunit (capns1) and a scrambled oligo (Scr) were included as positive
and negative controls, respectively. Knockdown efficiency was maximal at 72 hours
post-transfection, which corresponded with parasite-mediated cytolysis in this cell type
(~50 hpi). Following synchronous T. gondii infection (Kafsack et al., 2004), plates were
fixed and imaged at 6, 24, 44, or 60 hpi to assess parasite life cycle progression through
cytolysis. Genes involved in parasite-mediated cytolysis showed an accumulation of PVs
containing >64 parasites at 60 hpi upon knockdown (Z score +1.5, p < 0.05), ~10 hours
after host cell rupture typically occurs in this cell type.
From this screen, we initially identified 5 gene families whose knockdown blocked
parasite-mediated host cell cytolysis: calmodulin (CaM), Ca2+/calmodulin dependent
kinases (CaMK), Gα subunits (Gα), phospholipase C (PLC) and protein kinase C (PKC)
(Figure 7B). To deconvolute the specific genes required for parasite-mediated cytolysis
from these gene family hits, we tested two unique siRNAs targeting individual and pairs
of genes (Figure 7C, Table 5). We determined that single knockdown of gnaq
(p<0.002), and knockdown of the gene pairs prkca/prkcb (p<0.002), plcb1/plcg1
(p<0.002), calm1/calm2 (p<0.05) and camk1/camk2a (p<0.05), showed a statistically
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significant and correlated accumulation of unruptured PVs at 60 hpi (r=0.91; Figure 7D).
Stable shRNA-mediated knockdown of these genes had no effect on parasite doublings,
reinforcing their function in cytolysis rather than parasite replication (Figure 7E). shRNA
knockdown efficiency using multiple oligos was measured by western blot analysis of
total protein as compared to scr (Figure 7F). Representative images are shown for
shRNA knockdown cell lines that resulted in an accumulation of unruptured PVs in
comparison to controls (scr) or negatives (prkaca/prkacb) that show newly reinvaded
parasites at 60 hpi (Figure 7G).
Immunodepletion studies indicate conserved host protein function in P.
falciparum-mediated cytolysis
We next investigated whether the protein products of the validated gene hits in T.
gondii functioned similarly in P. falciparum-induced erythrocyte cytolysis, via antibodymediated depletion studies. To do this, erythrocytes were hypotonically lysed prior to
incubation with target antibodies preconjugated to sepharose beads. Removal of the
target protein-antibody conjugates were achieved via centrifugation and manipulated
erythrocytes were hypertonically resealed prior to P. falciparum infection. Efficiency of
target protein immunodepletion in erythrocytes was determined by western blot and only
immunodepletions showing >80% knockdown were further analyzed (Figure 9A;
(Chandramohanadas et al., 2009). Synchronous P. falciparum parasites were assessed
for life cycle progression by Giemsa smear (Figure 9B) and flow cytometry of DNA
content (Figure 9C; Figure 10) to distinguish blocked multinucleated schizonts from
newly invaded, ring-form parasites with a single nucleus. Immunodepletion of Gαq,
PLCβ1, CaM-1, or the simultaneous immunodepletion of both PKCα and PKCβ resulted
in an accumulation of schizont stage parasites and a lack of newly invaded rings at 60
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hpi, indicating a block in parasite-mediated cytolysis and corroborating the results of our
RNAi screen in T. gondii host cells. To assess parasite viability, trapped parasites were
mechanically released from depleted host cells and assessed for their invasive capacity
via flow cytometric quantitation of mononuclear ring-stage parasites 12 hours following
mechanical release (Figure 9D). Parasites trapped within erythrocytes were able to
recover invasive capacity upon needle-shearing only up to 54 hpi, indicating that
parasite death likely occurs following 6 hours of blocked cytolysis.
Host PKC is Activated During Schizogony to Remove Adducin from the Host
Cytoskeleton
As PKC is a major downstream effector of Gαq-coupled GPCR signaling via PLCmediated generation of diacylglycerol (DAG; (Castagna et al., 1982; Rhee et al., 1989)
and PKC inhibitors showed potent antiparasitic activity and the ability to block parasitemediated cytolysis in vitro (Figure 12A), we were interested in understanding the role of
this critical host enzyme in parasite life cycle progression. To measure host PKC activity
during the P. falciparum life cycle, we generated a transgenic P. falciparum line that
secretes a FRET-based PKC activity indicator (CKAR; (Violin et al., 2003) into the
infected erythrocyte cytoplasm (3D7-CKAR) via expression of a chimeric construct with
an N-terminal signal peptide and PEXEL motif (Gallegos et al., 2006; Hiller et al., 2004;
Marti et al., 2004; Violin et al., 2003). Figure 11A displays the specificity of the CKAR
reporter for PKC activity with representative positive control FRET images (maximal
FRET signal) of 3D7-CKAR-infected erythrocytes treated with the PKC agonist phorbol
myristate acetate (PMA) and negative control images (minimal FRET signal) upon
treatment with the PKC inhibitor Gö6976 or PKC immunodepletion prior to infection. As
with any protein present in the erythrocyte cytoplasm, a significant amount of CKAR was
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taken up into the parasite digestive vacuole, causing an intense CKAR FRET signal
within this organelle likely due to intermolecular FRET. In order to account for this artifact
in our measurements of host PKC activity, 3D7-CKAR parasites were removed from
their host cells and intracellular FRET signal was quantified to assess this background
signal within the digestive vacuole (Figure 12C). By FRET microscopy (Figure 11B) and
background-corrected fluorometry to remove digestive vacuole signal (Figure 11C), we
show limited host PKC activity throughout the ring and trophozoite stages (0-25 hpi) with
a sharp increase during schizogony (30-40 hpi). Immunodepletion of Gαq or PLCβ1
ablates PKC activity during the entire infectious cycle, reinforcing the importance of the
host Gαq signaling pathway upstream of PKC activation (Figure 12D). PMA restored
PKC activity in these parasite-infected erythrocytes depleted of signaling components
and also rescued the associated exit defect (Figure 12E), further indicating a critical role
for host PKC. PKC activity reporter cell lines were also generated via stable expression
of CKAR in U2OS host cells prior to T. gondii infection. The CKAR signal output
throughout the T. gondii life cycle in these reporter U2OS cells largely mirrored the
results obtained in P. falciparum, with maximal FRET signal occurring in the last third of
the intracellular life cycle (Figure 11D-F). Knockdown of host gnaq or plcb1/plcg1
ablates PKC activity but this activity was restored by the PKC agonist PMA (Figure
11H,I).
In a previous chapter, we have shown that the host cytoskeletal protein adducin is
lost from the erythrocyte actin cytoskeleton at ~35 hpi of P. falciparum in a calpainindependent manner (Millholland et al., 2011). As adducin cytoskeletal association is
regulated by the PKC-mediated phosphorylation of residues S716/S726 (Matsuoka et
al., 1996), we assessed PKC depletion on host adducin cytoskeletal association during
	
   50	
  
	
  

parasite infection. Western blot and immunofluorescence analysis of host cytoskeletal
fractions confirms adducin disappearance from both P. falciparum-infected erythrocytes
(Figure 11G, top; Figure 12F) and T. gondii-infected U2OS cells late in the intracellular
cycle (Figure 11H, top; Figure 12G). However, PKCα/β immunodepletion from
erythrocytes (Figure 11G, bottom) or shRNA knockdown in U2OS cells (Figure 11H,
bottom) abrogates this loss and maintains adducin cytoskeletal association through the
end of both parasite life cycles. The S716/S726 phosphorylated adducin species (padducin) accumulates in mock-treated cells in the last third of the life cycle by western
blot while the unphosphorylated form is lost from cytoskeletal fractions, unless PKCα/β is
depleted from host cells. Gαq or PLCβ1 immunodepletion from erythrocytes (Figure
12F), or knockdown in U2OS cells (Figure 12G) also caused adducin persistence within
the host cytoskeleton, highlighting the function of this upstream cascade.
In order to examine the effect of adducin persistence on T. gondii life cycle
progression, we overexpressed the PKC phospho-mutant adducin (S716A/S726A;
(Matsuoka et al., 1998) as well as wild-type adducin in host A549 cells. S716A/S726A
adducin expression resulted in minimal phosphorylation by western blot upon T. gondii
infection (Figure 11I), while wild-type adducin overexpressors show an abundance of padducin. Similar to PKCα/β stable knockdown, S716A/S726A adducin expression
resulted in the persistence of enlarged vacuoles by 60 hpi (Figure 11J,K), with no effect
on parasite replication (Figure 11L), suggesting that PKC-induced adducin loss directly
mediates host cell cytolysis. Tachyzoites trapped within host cells show reduced viability
following 18-24 hours of blocked cytolysis within host cells expressing the adducin
phospho-mutant S716A/S726A, similar to PKC inhibition or knockdown (Figure 12B),
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highlighting the feasibility of targeting this phase of the parasite life cycle as an
antiparasitic strategy.
Host signaling cascade is required for calpain-mediated cytoskeletal proteolysis
Host calpain activation has been shown to result in cytoskeletal proteolysis
necessary for parasite exit (Chandramohanadas et al., 2009; Millholland et al., 2011).
We thus assessed calpain activation following immunodepletion of signaling components
from erythrocytes using an activity-based probe for cysteine proteases, DCG04 (Figure
13A;

(Greenbaum

et

al.,

2000).

As

opposed

to

negative

control

PKAα/β

immunodepleted cells which show a clear active calpain band at the conclusion of the
life cycle, PKCα/β, PLCβ1, and Gαq immunodepletion disallows calpain activation,
similar to calpain immunodepleted cells. CaM-1 immunodepletion resulted in diminished
calpain activation, indicating that CaM-1 may facilitate this process. As a corollary to
calpain activation, we examined spectrin cleavage via western blot, a key calpain
substrate. Immunodepletion of pathway components abrogates spectrin proteolysis in P.
falciparum-infected erythrocytes at 50 hpi, while PKAα/β-immunodepleted cells show
multiple spectrin fragments (Figure 13B). Interestingly, in vitro incubation of U2OS cell
membrane fractions with activated CaMKII prior to incubation with calpain resulted in
multiple

spectrin

cleavage

products

(Figure

13C),

suggesting

that

CaMKII

phosphorylation of cytoskeletal substrates may enhance calpain-mediated proteolysis.
CaMKII activation is shown by CaM-1 co-immunoprecipitation and autophosphorylation
by p-CaMKII western blot analysis near the end of the T. gondii life cycle (Figure 13D),
suggesting that host CaMKII activity may enhance cytoskeletal proteolysis to facilitate
parasite release.
Analysis of host Ca2+ dynamics Implicates TRPC6 in Ca2+ influx
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Finally, we determined changes in host [Ca2+] that drive this network. To assess
erythrocyte [Ca2+] during P. falciparum infection, we confined a Ca2+ indicator to the
erythrocyte space via loading of a fura-2-dextran conjugate. Within the U2OS cell
cytoplasm during T. gondii infection, Ca2+ measurements were achieved via expression
of the ratiometric FRET-based Ca2+ indicator yellow cameleon 3.6 (YC3.6) in U2OS
cells (Nagai et al., 2004; Palmer and Tsien, 2006). By microscopy and backgroundcorrected fluorometry (Figure 14A,B), we show the relative changes in host cell [Ca2+] to
be similar between both parasite systems, with host [Ca2+] hovering near resting levels
(100 nM) throughout the first two-thirds of the life cycle, followed by a sharp increase in
[Ca2+] at the point of parasite release.
Given the large [Ca2+] increase seen in both T. gondii and P. falciparum host cells,
we further hypothesized that host plasma membrane cation channels play a role in this
influx. siRNA-mediated knockdown studies of mechanosensitive transient receptor
potential (TRP) channels (trpc1, trpc3, trpc6) as well as canonical endoplasmic reticulum
Ca2+ channels (ryr3, ip3r1) identified TRPC6 as a specific mediator of T. gondii exit, as
trpc6 knockdown resulted in an accumulation of unruptured vacuoles by 60 hpi (p<0.05;
Figure 14C,D). Trpc6 knockdown using multiple siRNA oligos abrogated the large
increase in cytoplasmic [Ca2+] while ip3r1 knockdown diminished the initial minor
increase in [Ca2+] observed earlier in T. gondii infection, indicating that PLC activity and
generation of IP3 may be responsible for the minor increase in [Ca2+] seen only in T.
gondii-infected cells (Figure 14E).
Pharmacological studies in P. falciparum-infected erythrocytes confirmed the
importance of mechanosensitive cation channel function in parasite-mediated cytolysis
(Figure 15A). [Ca2+] diminished in cells depleted of Gαq, PLCβ, or PKCα/β (Figure
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15B,C), but was rescued by PKC activation with PMA in cells depleted of Gαq or PLCβ,
indicating that PKC activity facilitates later Ca2+ influx, perhaps via adducing
phosphorylation and loss. PMA could not rescue Ca2+ influx in cells depleted of PKCα/β,
further confirming the necessity of PKC activity for this process. Taken together, these
data highlight the importance of TRPC6-mediated cation influx in host cell cytolysis,
perhaps as a mechanosensitive response to cytoskeletal rearrangement.
Mammalian PKC inhibitor demonstrates anti-parasitic activity in vivo
In order to assess the importance of this signaling cascade in parasitic disease
progression, we endeavored to test inhibition of this cascade on parasite burden in vivo.
Given that PKC has been targeted for drug development efforts in multiple disease
contexts from cancer to transplant rejection, and there are no known orthologs of the
classical PKC enzymes in apicomplexan genomes, we undertook studies of known PKC
inhibitors in murine models of malaria and toxoplasmosis. Intravenous injection of 10
mg/kg Gö6976, an inhibitor of classical mammalian PKC enzymes, caused a significant
decrease in parasitemia in a mouse P. yoelii malaria model in the classic 4-day Peter’s
suppression test (Figure 16A). Similarly, intraperitoneal injection of 10 mg/kg Gö6976
limited T. gondii parasite burden in both the spleen (p<0.0001; Figure 16B, top) and
peritoneal exudate cells (p<0.0001; Figure 16B, bottom). The consistency in
antiparasitic activity in vivo further suggests the importance of host PKC function in both
parasitic infections and underscores the conserved function of this host-signaling
pathway.
As further corroboration of the central role of host PKC in severe malaria, we
undertook studies of the orally-bioavailable specific PKC inhibitor sotrastaurin in a
mouse model of experimental cerebral malaria (Figure 16C,D). This inhibitor has
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passed Phase I trials and is undergoing Phase II trials for numerous indications (Budde
et al., 2010; Friman et al., 2011; Wagner et al., 2009), underscoring its potential as an
antimalarial drug candidate. 50 mg/kg by gastric gavage in a standard 4-day Peters’
suppression test led to a significant decrease in P. berghei ANKA parasitemia
(p<0.0001; Figure 16C) and significantly increased survival versus vehicle-treated
controls (p=0.0029; Figure 16D). We show direct translation of biological discovery to
therapeutic design: identification of this host signaling activity translates directly to a drug
discovery effort, as known inhibitors of extensively-studied host PKC enzymes control
parasitic disease in vivo. Given the multitude of other active proteins within the cascade,
it is clear that these newly identified host mediators of parasite-induced cytolysis
represent an untapped resource of antiparasitic targets.
TCA metabolites may initiate the cytolytic cascade through interaction with
Gα q-coupled GPCRs
As Gαq, PLC, and PKC converge in established GPCR signaling networks, we
hypothesized that GPCRs may play a role in initiation of this host pathway. Considering
that parasites do not encode GPCRs, we suggest a parasite-derived small molecule
ligand may signal to GPCRs of host origin through direct interaction with the host cell
membrane to mediate signaling through Gαq. We found it striking that several parasite
metabolites

peak

during

schizogony,

especially

the

TCA

cycle

intermediate

alphaketoglutarate (αKG; (Olszewski et al., 2009). As αKG and other TCA cycle
intermediates including succinate have recently been shown to signal through Gαqcoupled GPCRs, such as oxoglutarate receptor 1 (oxgr1) and succinate receptor 1
(sucnr1; (He et al., 2004; Qi et al., 2004), we hypothesized that increased parasite
metabolism during periods of high replication may initiate host cell signaling leading to
	
   55	
  
	
  

cytolysis. To test this idea, we first confirmed by western blot analysis that OXGR1 and
SUCNR1 were found in erythrocytes (Figure 17A) and U2OS cells (Figure 17B) and not
in parasites. Immunofluorescence studies of both GPCRs revealed puncta on the host
plasma membrane in uninfected and infected cells; however, there was a surprising
enrichment on the PV membrane in both P. falciparum-infected erythrocytes and T.
gondii-infected U2OS cells. To test whether these host GPCRs play a role in the
signaling cascade, we undertook knockdown studies of metabolite-sensing GPCRs in
U2OS cells and assayed for delays in T. gondii-mediated cytolysis. Simultaneous
knockdown of oxgr1 and sucnr1 caused an accumulation of large PVs at 60 hpi (p<0.09)
versus negative control cells or knockdown of the Gαi–coupled lactate receptor gpr81, in
which cytolysis occurred by 52 hpi (Figure 17C, D).
To further validate the knockdown results, we assessed whether activation of
these host GPCRs occurs prior to parasite exit. To do this, we utilized commercially
available Chem-1 cell lines (Millipore) that allow direct measurement of specific GPCR
activity through overexpression of Gαq and only OXGR1 or SUCNR1, on a parent cell
line background which expresses few endogenous GPCRs. T. gondii infection of Chem1 cells overexpressing either OXGR1 or SUCNR1 showed GPCR activity (as measured
by Fluo-8 fluorescence) to persist during the last third of the parasite life cycle until
cytolysis (Figure 17E, F). Conversely, the parental Chem-1 cell line displayed limited
GPCR activity throughout the T. gondii life cycle and a significant delay in parasitemediated cytolysis (Figure 17G), further suggesting a role for metabolite-sensing
GPCRs. Satisfyingly, a mixture of exogenous αKG/succinate initiated a hastening of T.
gondii exit, occurring ~20 hours sooner than incubation with DMSO alone or lactate
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(Figure 17H). Furthermore, αKG/succinate induced premature lysis of P. falciparum
parasites leading to parasite death (Figure 17I).
Discussion
Host cell cytolysis was thought to be largely parasite-mediated, mainly due to
increasing pressure on the host cell membrane and cytoskeleton by the growing parasite
body (Glushakova et al., 2010; Glushakova et al., 2005). However, we have recently
shown that host calpain-mediated proteolysis of host cytoskeletal proteins is necessary
for parasite exit (Chandramohanadas et al., 2009; Millholland et al., 2011). In this work
we present a complex host-derived signaling pathway that functions in parasitemediated cytolysis, suggesting that host cell cytolysis is a highly regulated process
requiring a complex interplay of host-derived components.
We present a model (Figure 18) in which diffusion of parasite-derived small
molecule GPCR ligands outside into the PV space and host cell results in
overstimulation of host GPCRs. These GPCRs engage a Gαq-mediated signaling
pathway converging on PKC activation that results in the complete loss of a key
cytoskeletal component, and leads to pathological Ca2+ influx through mechanosensitive
plasma membrane TRP channels. Ca2+-charged host CaM activates CaMK which in turn
phosphorylates cytoskeletal substrates, increasing their propensity for calpain-mediated
proteolysis. Increasing cytoplasmic [Ca2+] induces global calpain activation which results
in the proteolysis of various substrates, and in turn causes the loss of host cell plasma
membrane integrity to allow for parasite release.
PKC and calpain play key roles within this cascade, a partnership that has been
underscored in other human pathologies related to GPCR overstimulation, including
glutamate

neuroexcitotoxicity

and

post-myocardial
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infarction

cell

death.

PKC

downregulation has been shown to protect against glutamate neurotoxicity (Ahlemeyer
et al., 2002; Favaron et al., 1990; Hasham et al., 1997), while calpain inhibition has been
shown to abrogate neuronal cell death (Witt et al., 1994) and block Ca2+ influx (Weiss et
al., 1990). Similarly, PKC and calpain are thought to play a role in post-myocardial
infarction ischemic cell death of multiple tissues (Bright et al., 2004; Padanilam, 2001;
Piccoletti et al., 1992; Speechly-Dick et al., 1994) as inhibitors of these enzymes offer
protective effects (Bevers et al., 2010; Bevers et al., 2009; Koponen et al., 2003; Neuhof
et al., 2008; Wagey et al., 2001; Wei et al., 2010). Though it is unclear whether the
sequential activation of these enzymes is necessary for cell death in these disease
contexts, we suggest that PKC activity is an essential upstream component of
pathological calpain activation in the context of parasite infection. Given the antiparasitic
activity of PKC inhibitors in mouse models of both toxoplasmosis and malaria, inhibition
of multiple host proteins upstream of PKC activity will likely limit parasite growth with low
propensity for generation of resistance in the field.
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Table 3. siRNA screen in U2OS cells Identifies Host Mediators of T. gondii-Induced Host Cell Cytolysis
SINGLE GENES
Means shown are representative of at least 3 separate experiments. N=3.
Gene
Symbol

Full Gene Name

LEGEND:

NEGATIVE CONTROL

Unruptured
Vacuoles/
Field
(44 hpi)

SEM
(44 hpi)

Unruptured
Vacuoles/
Field
(60 hpi)

SEM
(60 hpi)

GO Term

1.53

0.244

0.0427

0.0295

calcium ion binding, calciumdependent phospholipid binding,
phospholipase inhibitor activity

POSITIVE CONTROL
POSITIVE HIT
anxa1

annexin A1

59

anxa2

annexin A2

1.07

0.332

0.0632

0.0552

calcium ion binding, calciumdependent phospholipid binding,
phospholipase inhibitor activity
cytoskeletal protein binding

atp2a3

ATPase, Ca++ transporting,
ubiquitous

1.74

0.188

0.0222

0.0329

calcium ion transport, cation
transport

atp8b1

ATPase, aminophospholipid
transporter, class I, type 8B, member

1.432

0.182

0.0341

0.0328

ion transmembrane transport,
phospholipid transport, membrane
fraction

cabin1

calcineurin binding protein 1

1.69

0.152

0.0281

0.0388

cell surface receptor linked signaling
pathway

calcr

calcitonin receptor

1.14

0.127

0.0733

0.0621

plasma membrane, G-protein
signaling, coupled to cAMP
nucleotide second messenger

calm1

Calmodulin 1

1.94

0.159

0.147

0.0913

calcium ion binding, calciumdependent protein binding

calm2

Calmodulin 2

1.32

0.273

0.0986

0.0325

calcium ion binding, calciumdependent protein binding

camk1

calcium/calmodulin-dependent
protein kinase I

1.09

0.299

0.114

0.0374

signal transduction

calcium- and calmodulin-dependent
protein kinase complex; calmodulin
binding

calcium/calmodulin-dependent
protein kinase II alpha

1.53

0.263

0.195

0.0522

camk2b

calcium/calmodulin-dependent
protein kinase II beta

0.978

0.264

0.166

0.0426

capn1

calpain 1, (mu/I) large subunit

1.42

0.283

0.522

0.0893

capn2

calpain 2, (m/II) large subunit

1.19

0.174

0.476

0.0783

capn5

calpain 5

1.57

0.293

0.156

0.108

capns1

calpain, small subunit 1

1.21

0.273

1.21

0.214

gnaq

guanine nucleotide binding protein (G
protein), q polypeptide

1.48

0.284

1.08

0.412

gnai1

Guanine nucleotide binding protein
(G protein), alpha inhibiting activity
polypeptide 1

1.324

0.236

0.135

0.0316

G-protein coupled receptor protein
signaling pathway; signal transducer
activity

gnai2

Guanine nucleotide binding protein
(G protein), alpha inhibiting activity
polypeptide 2

1.24

0.331

0.0598

0.0566

G-protein coupled receptor protein
signaling pathway; signal transducer
activity

gnai3

Guanine nucleotide binding protein
(G protein), alpha inhibiting activity
polypeptide 3

1.05

0.364

0.214

0.0523

G-protein coupled receptor protein
signaling pathway; signal transducer
activity

gnas

guanine nucleotide binding protein (G
protein), alpha s

1.34

0.236

0.172

0.0615

G-protein coupled receptor protein
signaling pathway; signal transducer
activity

gna12

guanine nucleotide binding protein (G
protein), alpha 12

1.77

0.164

0.118

0.0427

G-protein coupled receptor protein
signaling pathway; signal transducer
activity

60

camk2a

calcium ion binding, calmodulin
binding
calcium ion binding, calciumdependent cysteine-type
endopeptidase activity
calcium ion binding, calciumdependent cysteine-type
endopeptidase activity
signal transduction, calciumdependent cysteine-type
endopeptidase activity
calcium ion binding, calciumdependent cysteine-type
endopeptidase activity
G-protein coupled receptor protein
signaling pathway; signal transducer
activity

gna13

guanine nucleotide binding protein (G
protein), alpha 13

0.96

0.234

0.0464

0.0634

G-protein coupled receptor protein
signaling pathway; signal transducer
activity

kcnn4

potassium intermediate/small
conductance calcium-activated
channel, subfamily N, member 4

1.24

0.236

0.1953

0.0597

plasma membrane, ion transport,
calcium-activated potassium channel
activity

lmna

lamin A/C

1.05

0.235

0.1655

0.0693

intermediate filament, structural
molecule activity

mylk

myosin light chain kinase
phosphoinositide-3-kinase, catalytic,
alpha polypeptide

1.09

0.296

0.112

0.0882

kinase activity

1.69

0.253

0.0821

0.0333

signal transduction
signal transduction

pik3ca

61

pik3cb

phosphoinositide-3-kinase, catalytic,
beta polypeptide

1.32

0.128

0.184

0.0413

pla2g4a

phospholipase A2, group IVA

1.22

0.237

0.142

0.0894

plcb1

phospholipase C, beta 1

1.65

0.385

0.121

0.0521

plcb2

phospholipase C, beta 2

1.21

0.236

0.0541

0.0433

plcb3

phospholipase C, beta 3

1.55

0.237

0.112

0.0323

plcd1

phospholipase C, delta 1

1.26

0.235

0.184

0.0166

plcg2

phospholipase C, gamma 2

1.34

0.384

0.193

0.0882

plcg1

phospholipase C, gamma 1

1.31

0.254

0.113

0.063

plscr1

phospholipid scramblase 1

1.47

0.295

0.144

0.0511

prkaca

protein kinase, cAMP-dependent,
catalytic, alpha

1.01

0.133

0.125

0.0417

prkacb

protein kinase, cAMP-dependent,
catalytic, beta

1.08

0.188

0.214

0.135

prkca

protein kinase C, alpha

0.953

0.213

0.242

0.0335

prkcb

protein kinase C, beta

1.09

0.223

0.0842

0.0446

calcium ion binding; calciumdependent phospholipase A2 activity
calcium ion binding, signal
transduction
calcium ion binding, signal
transduction
calcium ion binding, signal
transduction
calcium ion binding, signal
transduction
signal transduction, activation of
store-operated calcium channel
activity
calcium ion binding, signal
transduction
calcium ion binding, plasma
membrane
plasma membrane, cAMPdependent protein kinase inhibitor
activity
signal transduction, plasma
membrane
signal transduction, plasma
membrane
signal transduction, plasma

membrane
protein kinase C, gamma
protein phosphatase 3, catalytic
subunit, alpha isozyme

1.04

0.192

0.0655

0.0875

signal transduction

1.44

0.214

0.0541

0.114

calcium ion transport

ptk2

PTK2 protein tyrosine kinase 2

0.874

0.122

0.177

0.0552

cytoskeleton, plasma membrane

rac1

ras-related C3 botulinum toxin
substrate 1 (rho family, small GTP
binding protein Rac1)

1.41

0.216

0.0842

0.0224

plasma membrane, signal
transduction

rac2

ras-related C3 botulinum toxin
substrate 2 (rho family, small GTP
binding protein Rac2)

1.21

0.177

0.0831

0.0452

plasma membrane, signal
transduction

rhoa

ras homolog gene family, member A

0.915

0.131

0.113

0.0316

plasma membrane, cytoskeleton,
signal transduction

rhob

ras homolog gene family, member B

0.889

0.122

0.145

0.0332

plasma membrane, signal
transduction

Scr

scrambled oligo (negative control)

1.21

0.112

0.0731

0.0221

prkcg
ppp3ca
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Table 4. MULTI-ISOFORM FAMILIES AND CONSTITUENTS
Means shown are representative of 3 separate experiments. N=3.
Gene Family

Single Genes Included

LEGEND:

NEGATIVE CONTROL

Unruptured Vacuoles/ Field
(44 hpi)

SEM (44 hpi)

Unruptured Vacuoles/
Field (60 hpi)

SEM (60 hpi)

1.19

0.311

0.0594

0.0442

POSITIVE CONTROL
Annexin

POSITIVE HIT
anxa1
anxa2

63

Calmodulin
(CaM)

calm1
calm2

0.974

0.223

0.713

0.195

CaM Kinase

camk1
camk2a
camk2b

1.07

0.142

0.822

0.138

Calpain

capn1
capn2
capns1

1.17

0.281

0.973

0.155

G-alpha
subunits

gnaq
gnai1
gnai2
gnai3
gnas
gna12
gna13

1.11

0.262

0.842

0.155

Lamin

lmna
lmnb1
lmnb2

1.24

0.171

0.121

0.0997
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PI3-Kinase

pik3ca
pik3cb

0.892

0.174

0.112

0.164

Phospholipase
C

plcb1
plcb2
plcb3
plcd1
plcg2
plcg1

1.22

0.242

0.942

0.232

Protein Kinase
C

prkca
prkcb
prkcg

1.41

0.331

0.914

0.176

Rac GTPases

rac1
rac2

1.09

0.132

0.141

0.0571

Rho GTPases

rhoa
rhob

1.11

0.233

0.0912

0.0778

Table 5. GENE PAIRS
Gene (s)

Means shown are representative of 5 separate experiments. N=5.
Unruptured Vacuoles/Field
SEM
Unruptured Vacuoles/Field
(44 hpi)

LEGEND:

SEM

(44 hpi)

(60 hpi)

(60 hpi)

NEGATIVE CONTROL
POSITIVE CONTROL
POSITIVE HIT

Scr #1

1.53

0.244

0.233

0.071

Scr #2

1.07

0.332

0.103

0.099

capn1 #1

1.21

0.212

0.312

0.041

capn1 #2

1.33

0.155

0.441

0.198

capn2 #1

1.13

0.213

0.291

0.171
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capn2 #2

1.17

0.199

0.212

0.104

capn1 #1/capn2 #1

1.22

0.273

1.31

0.285

capn1 #2/capn2 #2

1.41

0.112

1.05

0.256

capns1 #1

1.74

0.188

1.83

0.265

capns1 #2

1.432

0.182

1.91

0.228

calm1 #1

1.69

0.152

0.243

0.243

calm1 #2

1.14

0.127

0.0166

0.0166

calm2 #1

1.33

0.166

0.132

0.078

calm2 #2

1.22

0.183

0.0664

0.015

calm1 #1/calm2 #1

1.44

0.151

1.06

0.311

calm1 #2/calm2 #2

1.32

0.273

1.09

0.416

camk1 #1

1.09

0.299

0.203

0.145

camk1 #2

1.53

0.263

0.206

0.118

camk2a #1

0.97

0.264

0.252

0.284

camk2a #2

1.42

0.283

0.241

0.144

camk2b #1

1.39

0.211

0.311

0.188

camk2b #2

1.44

0.24

0.16

0.0981

camk1 #1/camk2a #1

1.89

0.174

1.02

0.204

camk1 #2 /camk2a #2

1.57

0.293

1.18

0.393

camk1 #1/camk2b #1

1.41

camk1 #2/camk2b #2
camk2a #1/camk2b
#1
camk2a #2/camk2b
#2

1.29
1.33
1.11

0.31

0.033

0.0242

0.283

0.17

0.0886

0.137

0.41
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(A). Model of host siRNA screen for mediators of parasite-induced cytolysis. Defects in T. gondii-mediated cytolysis are scored at 60
hpi: parasites unable to exit persist as vacuoles with >64 parasites, while parasites able to exit host cells reinvade new cells. (B).
Primary siRNA screen in U2OS cells: unruptured vacuoles (intact vacuoles with >64 parasites) are compared at 44 and 60 hpi to identify
host gene involvement in parasite release (*p<0.05; **p<0.01). Data shown are mean unruptured vacuoles per field ± SEM	
  

Figure 7: siRNA screen identifies novel signaling components
required for T. gondii-mediated cytolysis. (A, B)
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(C). Secondary screen utilizing multiple oligos validates individual host genes and gene pairs whose knockdown resulted in
accumulation of unruptured vacuoles by 60 hpi. Data shown are mean unruptured vacuoles per field ± SEM. (D). Pearson correlation
graph indicates strong relation between siRNA oligos (r=0.91). (E). Parasite doublings measurements within stable shRNA knockdown
cell lines.	
  

Figure 7: siRNA screen identifies novel signaling components
required for T. gondii-mediated cytolysis. (C-E)
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(F). Western blot analysis confirms shRNA-mediated stable knockdown of target proteins, as compared to Scr oligo. (G).
Representative images of P30-GFP vacuoles in stable knockdown cell lines at 44 and 60 hpi.

Figure 7: siRNA screen identifies novel signaling components
required for T. gondii-mediated cytolysis. (F, G)

Figure 8. Design of siRNA screen to identify host genes required for
T. gondii-mediated cytolysis.

For the primary screen, pooled siRNAs targeting a select set of 50 genes and 8 multiple gene families (three
siRNAs/gene) were arrayed in collagen-coated 96-well plates (in quadruplicate), reverse-transfected into
U2OS cells. Following synchronous T. gondii infection at 24 hours post-transfection, plates were fixed and
imaged by fluorescence microscopy at 6, 24, 44 or 60 hpi. Image analysis was used to calculate parasite
doublings as a measure of parasite replication and parasites per PV to assess progression of the entire
intracellular parasite life cycle including cytolysis. Hits were selected based on persistence of large vacuoles
at 60 hpi. The secondary screen included 19 individual genes and degenerate pairs of the multiple gene
family hits, for a total of 17 multiple gene knockdowns using multiple oligos for validation. Hits from the
secondary screen (individual genes or gene pairs) were tested in the final screen in 24-well plates.
Images/western blots of stable shRNA knockdown cells were utilized in Figure 7F,G.
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(A). Immunodepletion studies of soluble erythrocyte protein hits confirmed by western blot (M: Mock; ID: immunodepletion; IP:
immunoprecipitation – target protein elution from sepharose beads). (B). Representative Giemsa images following immunodepletion
of host Gαq, PLCβ1, PKCα/β, and CaM-1 results in persistence of schizont stage parasites by 60 hpi versus mock or PKAα/βcat
depletion, which resulted in exit and reinvasion by 60 hpi.	
  

Figure 9: Conserved function of host proteins in P. falciparummediated cytolysis. (A, B)
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(C). Flow cytometric quantitation of schizont-stage (left) and ring-stage (right) parasites in depleted erythrocytes. Data shown are means
of at least three experiments ± SEM (**p<0.01) (D). Ring parasitemia assessed 12 hours following needle shearing of infected, depleted
erythrocytes at the times indicated (ND: Not determined; **p<0.01; *p<0.05). Data shown are means of at least three experiments ± SEM.

Figure 9: Conserved function of host proteins in P. falciparummediated cytolysis. (C, D)

Figure 10. Depletion of PLCβ1 and calmodulin-1 from erythrocytes is
sufficient to block P. falciparum-mediated cytolysis.

(A). Erythrocytes depleted of either PLCβ1, PLCγ, or both PLCβ1 and PLCγ were assayed for schizont
persistence (left panel) or reinvasion of new rings (right panel) at 60 hpi. Though PLCβ1 depletion caused a
significant persistence of schizont stage parasites and a reciprocal decrease in newly reinvaded rings
(*p<0.05), indicating a block in cytolysis, PLCγ depletion did not alter normal life cycle progression. Dual
depletion of both PLCβ1 and PLCγ did not significantly exaggerate the block in cytolysis from PLCβ1 alone,
indicating that PLCγ does not have a significant role in this process. Data shown are means of at least 3
experiments +/- SEM; n=3. (B). Erythrocytes depleted of either calmodulin-1, calmodulin-2, or both
calmodulin-1 and calmodulin-2 were assayed for schizont persistence (left panel) or reinvasion of new rings
(right panel) at 60 hpi. Though calmodulin-1 depletion caused a significant persistence of schizont stage
parasites and a reciprocal decrease in newly reinvaded rings, indicating a block in cytolysis (*p<0.05),
calmodulin-2 depletion did not alter normal life cycle progression. Dual depletion of both calmodulin-1 and
calmodulin-2 did not significantly exaggerate the block in cytolysis from calmodulin-1 alone, indicating that
calmodulin-2 does not have a significant role in this process. Data shown are means of at least three
experiments +/- SEM; n=3.
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(A-C). Assessment of host PKC activity through imaging and fluorometry of 3D7-CKAR P. falciparum parasites. (A). Representative control
FRET images at 35 hpi. Positive control: 100 nM PMA; negative controls: PKCα/β depletion, 500 nM Gö6976. (B). Representative FRET
images through the P. falciparum intracellular cycle. (C). CFP/YFP FRET fluorometry as a measurement of host PKC activity throughout
the P. falciparum cycle. Data shown are mean fluorescence of at least three experiments ± SEM (**p<0.01).

Figure 11: Host PKC is activated late in the parasite intracellular cycle
and abrogates host adducin cytoskeletal association. (A-C)
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(D-F). Assessment of host PKC activity through imaging and fluorometry of T. gondii-infected U2OS cells expressing cytoplasmic CKAR. (D).
Representative control FRET images at 5 parasite divisions. Positive control: 100 nM PMA; negative controls: PKCα/β knockdown, 500 nM
Gö6976. E. Representative FRET images through the T. gondii intracellular cycle. (F). CFP/YFP FRET fluorometry as a measurement of host
PKC activity throughout the T. gondii cycle. Data shown are mean fluorescence of at least three experiments ± SEM (**p<0.01).	
  

Figure 11: Host PKC is activated late in the parasite intracellular
cycle and abrogates host adducin cytoskeletal association. (D-F)

(G). Western blot analysis of erythrocyte cytoskeletal fraction through P. falciparum cycle in mock-treated erythrocytes (top) or
erythrocytes depleted of PKCα/β (bottom). Loading control: actin. (H). Western blot analysis of U2OS cytoskeletal fraction through T.
gondii cycle in mock-treated cells (top) or PKCα/β-stable knockdown cells (bottom). Loading control: actin.

Figure 11: Host PKC is activated late in the parasite intracellular cycle
and abrogates host adducin cytoskeletal association. (G, H)
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(I). Western blot analysis of A549 cytoskeletal fractions upon adducin mutant expression, following T. gondii infection at 44 hpi, compared to
capns1 or prkca/prkcb stable knockdown. Add1+: adducin overexpression; S716A/S726A: PKC phospho-mutant adducin expression.
Loading control: actin. (J). Representative 60 hpi images of T. gondii vacuoles at 60 hpi (following host cell manipulation as in I). (K).
Quantitation of unruptured vacuoles at 60 versus 44 hpi (following host cell manipulation as in I). Data shown are means of at least 4
experiments ± SEM (**p<0.01). (L). Parasite doublings throughout life cycle (following host cell manipulation as in I).

Figure 11: Host PKC is activated late in the parasite intracellular cycle
and abrogates host adducin cytoskeletal association. (I-L)
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(A). PKC inhibitor IC 50 values and percent parasite reinvasion upon 500 nM treatment on P. falciparum and T. gondii. Data shown are
means of at least three experiments +/- SEM; n=3. (B). T. gondii viability following block of host cell cytolysis in host cells upon Gö6976
treatment, PKCα/β knockdown, or S716A/S726A adducing expression. Data shown are mean T. gondii viability upon mechanical
release at the timepoints shown following arrest at egress, of at least 3 experiments +/- SEM.

Figure 12. Host Gαq and PLCβ1/γ1 are required upstream for host
PKCα/β function in adducin loss prior to parasite-mediated cytolysis.
(A, B)
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Figure 12. Host Gαq and PLCβ1/γ1 are required upstream for host
PKCα/β function in adducin loss prior to parasite-mediated cytolysis.
(C-E)

(C). 3D7-CKAR parasites removed from their host cells via saponin treatment were assessed for
CKAR fluorescence to account for digestive vacuole uptake. Representative 30-hour image (left) and
population-based fluorometry throughout the life cycle (right) show digestive vacuole fluorescence,
which is removed as background from all 3D7-CKAR measurements in Figure 12. Data shown are
means of at least three experiments +/- SEM; n=4. (D). 3D7-CKAR fluorescence at 35 hpi following
immunodepletion of key host signaling components. Representative images show that Gαq and
PLCβ1 immunodepletion diminished CKAR signal in the host cell compartment, which was rescued
by 100 nM PMA. Data shown are means of at least three experiments +/- SEM. (E). Erythrocyte
CKAR FRET-based fluorescence of 3D7-CKAR parasites and life cycle progression as measured by
quantitation of ring stage parasites at 60 hpi following depletion of Gαq or PLCβ1. Data shown are
means of at least three experiments +/- SEM
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(F). Adducin immunofluorescence and western blot of erythrocyte cytoskeletal fractions at 35 hpi of P. falciparum following knockdown of
key signaling components. PMA rescues adducin loss following depletion of Gαq or PLCβ by immunofluorescence (left) or western blot
(right). PMA could not induce adducin loss following depletion of PKCα/β. (G). Adducin immunofluorescence and western blot of U2OS
cell cytoskeletal fractions at 5 parasite divisions following knockdown of key signaling components. PMA rescues adducin loss following
knockdown of gnaq or plcb1/plcg1 by immunofluorescence or western blot. PMA could not induce adducin loss following prkca/prkcb
knockdown.

Figure 12. Host Gαq and PLCβ1/γ1 are required upstream for host
PKCα/β function in adducin loss prior to parasite-mediated cytolysis.
(F,G)
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(H). CKAR FRET-based fluorescence at 5 T. gondii divisions following stable knockdown of key host signaling components.
Representative images show that gnaq or plcb1/plcg1 knockdown diminished CKAR signal in the host cell compartment,
which was rescued by 100 nM PMA. Data shown are means of at least three experiments +/- SEM. I. CKAR FRET-based
fluorometry within T. gondii-infected U2OS cells at 5 parasite divisions. PMA addition rescues PKC activity following depletion
of gnaq or plcb1/plcg1. Data shown are means of at least three experiments +/- SEM.

Figure 12. Host Gαq and PLCβ1/γ1 are required upstream for host
PKCα/β function in adducin loss prior to parasite-mediated cytolysis.
(H,I)
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Figure 13: Host signaling cascade enhances calpain-mediated
cytoskeletal proteolysis just prior to parasite exit.

(A). DCG04-labeling of active calpain in P. falciparum-infected erythrocyte fractions at 50 hpi in cells
depleted of Gαq, PLCβ1, PKCα/β, and CaM-1 by immunodepletion. Biotin blot confirms calpain activity upon
labeling. Negative control: Calpain-1 depletion; positive control: PKAα/β depletion; loading control: actin. (B).
α−Spectrin cleavage by western blot at 50 hpi in erythrocyte cytoskeletal fractions following depletion of
signaling components. (C). α−Spectrin cleavage by western blot following in vitro incubation of U2OS cell
cytoskeletal fractions with activated CaMKII prior to incubation with recombinant human calpain-1. (D). Host
CAMKII/calmodulin-1 coimmunoprecipitation through the T. gondii life cycle and presence of p-CAMKII (the
activated form) by western blot.
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(A). Representative images of erythrocytes loaded with Fura-2-dextran prior to challenge with synchronous P. falciparum
2+
parasites (left). [Ca ] as a function of 340nm/380nm emission ratio (right). Data shown are mean calcium measurements of
at least 3 experiments ± SEM.

Figure 14: Host [Ca2+] increases throughout the last third of the
intracellular cycle, in a TRPC6-dependent manner. (A)
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2+

(B). Representative images of T. gondii-infected U2OS cells expressing YC3.6 (left). [Ca ] as a function of CFP/YFP
2+
FRET (right). Data shown are mean Ca measurements of at least three experiments ± SEM.

Figure 14: Host [Ca2+] increases throughout the last third of the
intracellular cycle, in a TRPC6-dependent manner. (B)
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Figure 14: Host [Ca2+] increases throughout the last third of the
intracellular cycle, in a TRPC6-dependent manner. (C,D)

(C) Representative images and quantitation (D) at 44 and 60 hpi of siRNA-mediated knockdown of
cation channels prior to T. gondii infection. Positive control: Capns1; negative control: scr oligo. Data
shown are mean unruptured vacuoles per field ± SEM (*p<0.05; **p<0.01).
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Figure 14: Host [Ca2+] increases throughout the last third of the
intracellular cycle, in a TRPC6-dependent manner. (E)

2+

(E). Representative images (left) and [Ca ] measurements as a function of CFP/YFP FRET (right) at 5 T.
gondii divisions (~35 hpi) following siRNA-mediated knockdown of cation channels in U2OS cells expressing
2+
YC3.6. Data shown are mean Ca measurements ± SEM.
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Figure 15. PKC activity, as mediated by Gαq and PLC, is required for
Ca2+ influx at the end of the parasite life cycle. (A, B)

A). Giemsa images at specified timepoints following treatment beginning at 30 hpi with 500 nM cation
channel inhibitors GsTMx-4, 2-APB, SKF-63563, or Pyr3. (B). Population level measurement of schizont
persistence (left) and new ring formation (right) following inhibition of cation channel inhibitors at 30 hpi.
Data shown are means of at least three experiments +/- SEM; *p<0.05; **p<0.01.
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Figure 15. PKC activity, as mediated by Gαq and PLC, is required for
Ca2+ influx at the end of the parasite life cycle. (C)

(C). Representative FRET images and population level fluorometry at 5 T. gondii parasite divisions of U2OS
2+
cells expressing YC3.6 following knockdown of gnaq, plcb1/plcg1, or prkca/prkcb show that [Ca ] is limited
2+
upon knockdown of these signaling members. 100 nM PMA treatment rescues Ca influx following gnaq or
plcb1/plcg1 knockdown, though it cannot be rescued following prkca/prkcb knockdown. Data shown are
means of at least three experiments +/- SEM.
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Figure 15. PKC activity, as mediated by Gαq and PLC, is required for
Ca2+ influx at the end of the parasite life cycle. (D)

2+

(D). Representative 45 hpi images and population-level Ca measurements of P. falciparum-infected
2+
erythrocytes loaded with Fura-2-dextran, and immunodepleted of Gαq, PLCβ1, or PKCα/β. Ca influx was
limited in cells depleted of these effectors, but could be rescued upon PMA treatment following Gαq or
2+
PLCβ1 depletion. The mechanosensitive channel inhibitor GsTMx-4 abrogated PMA-induced Ca influx,
indicating that is influx is cation channel-dependent. Data shown are means of at least three experiments +/SEM.
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Figure 16

Figure 16: Mammalian PKC inhibitors show antiparasitic activity in vivo. (A). P. yoelii parasitemia
quantified via Giemsa tail vein blood smear upon intravenous injection of 10 mg/kg Gö6976 once daily for 4
days. (n=10; ***p<0.001). (B). T. gondii parasite burden in cells from the spleen (top) and peritoneal cavity
(PECS; bottom) upon intraperitoneal injection of 10 mg/kg Gö6976, quantified by flow cytometry. Plots
shown are gated on single, live cells by FSC and SSC. (n=15 for all conditions; ***p<0.0001). (C). P. berghei
ANKA parasitemia quantified via Giemsa tail vein blood smear upon 50 mg/kg Sotrastaurin treatment via
gastric gavage once daily for 4 days. (n=7 for all conditions; ***p<0.0001). Shown are mean parasitemias ±
SEM. (D). Survival curves following sotrastaurin treatment using the standard Mantel-Cox log rank test
(**p=0.0029).
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Figure 17: Parasite TCA cycle intermediates initiate the host cytolytic
network. (A, B).

Immunofluorescence of OXGR1 and SUCNR1 within P. falciparum-infected erythrocytes (A) and T. gondii–
infected U2OS cells (B). Western blots are included as a control. (A: Red- OXGR1 (top panel)/SUCNR1
(bottom panel), Green- His-GFP (PV); (B): Red– OXGR1 (top panel)/SUCNR1 (bottom panel), Green- P30GFP (PV).
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Figure 17: Parasite TCA cycle intermediates initiate the host cytolytic
network. (C,D)

(C). Western blot confirmation of siRNA-mediated knockdown of host GPCRs and the positive control
CAPNS1. Representative images of P30-GFP-infected U2OS knockdown cells at 44 and 60 hpi. (D).
Quantitation of enlarged vacuoles through 60 hpi. Data shown are means of at least three experiments +/SEM.
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Figure 17: Parasite TCA cycle intermediates initiate the host cytolytic
network. (E-G)

(E,F). Host OXGR1 and SUCNR1 activity following T. gondii infection via measurement of Fluo-8
fluorescence. Representative images (E) and Fluo-8 fluorescence (F) indicate host GPCR activity
throughout the parasite life cycle. Data shown are mean fluorescence +/- SEM. (G) Unruptured vacuoles
measured at 48 hpi following T. gondii infection of cells used in (E, F).
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Figure 17: Parasite TCA cycle intermediates initiate the host cytolytic
network. (H, I)

(H). Time until T. gondii parasite exit upon treatment with 50 µM exogenous aKG/succinate or 50 µM lactate,
versus 10 µM A23187 (positive control for egress induction). Data shown are mean time of at least 3
experiments +/- SEM. (I). Representative Giemsa images following a 12-hour treatment with 50 µM
exogenous aKG/succinate, lactate, or DMSO control.
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Figure 18: Model of host GPCR-mediated cytolysis.

Parasite ligands, perhaps upregulation of parasite TCA cycle intermediates during periods of high parasite
replication, activate GPCRs on the PV membrane and initiate a signaling cascade through host Gαq. PKCmediated phosphorylation liberates adducin from the host cell cytoskeleton, activating the mechanosensitive
2+
plasma membrane cation channel TRPC6. CaMKII-activation following Ca influx mediates phosphorylation
2+
of cytoskeletal substrates, which, upon rapid influx of Ca from the extracellular media, are proteolyzed by
calpain to allow for cytoskeletal dissolution and parasite release.
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VI. Human Platelet Factor 4 and synthetic mimics:
Harnessing host defense mechanisms for parasite death by ulcer
The pathogenesis of malaria is modulated both positively and negatively by many
human cell types in blood including monocytes, neutrophils and platelets (de Mast et al.,
2007; Gimenez et al., 2003; Goodier et al., 1995; Krupka et al., 2012; Mohanty et al.,
1997; Pain et al., 2001). While platelets have been long known to interact cooperatively
with erythrocytes in thrombogenesis, both generally and in the specific case of sickle cell
disease (Rocca and FitzGerald, 1997), only recently have platelets been shown to bind
infected erythrocytes and kill intracellular malaria parasites (McMorran et al., 2009).
Previous studies have suggested that thrombocytopenia is a poor prognostic marker in
malaria (Moerman et al., 2003) and is significantly associated with cerebral malaria (Cox
and McConkey, 2010; Wassmer et al., 2008). We were intrigued by the idea that these
host cells found in the bloodstream are known to secrete proteins with host defense
peptide activity (HDPs) (McMorran et al., 2009; Tang et al., 2002), and the possibility
that these proteins could be responsible for controlling malaria parasite proliferation in
the blood stage.
HDPs play a central role in the innate immune system (Finlay and Hancock, 2004;
Hancock and Lehrer, 1998; Tossi et al., 2000; Zasloff, 2002). Over 700 HDPs have been
identified, varying in length, sequence, and tertiary structure. There are two classes of
HDPs comprising ribosomally and nonribosomally synthesized peptides: α-helical (i.e.
magainin and cecropin) and disulfide-rich β-sheets (i.e. bactenecin and defensin),
although other tertiary structures also exist. Importantly, HDPs display broad-spectrum
action against bacteria, fungi, protozoa, and viruses, which has promoted their use as
new leads for developing antibiotics (Zasloff, 2002). HDPs share common features
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including amphipathic topologies in which the cationic and hydrophobic side chains
segregate onto distinctly opposing regions or faces of the overall folded conformation.
Furthermore, numerous studies with linear and cyclic peptides have strongly supported
the hypothesis that the physicochemical properties of HDPs, rather than any specific
sequence or structure, are responsible for their activities. HDPs are thought to bind the
membrane surface in a non-cooperative fashion and then aggregate once a threshold
concentration is reached causing membrane permeabilization (Christensen et al., 1988;
Ludtke et al., 1995; Matsuzaki et al., 1995, 1996; Pouny et al., 1992). It is generally
believed that amphipathic topology is essential for insertion into and disruption of
membranes leading to pathogen death (Zasloff, 2002). HDPs have remained an effective
weapon against pathogen infection over time indicating that their mechanism of action
thwarts pathogen responses, which normally lead to resistance against toxic
substances. This premise is supported by data showing that no appreciable resistance
to the action of the HDPs occurs after multiple serial passages of bacteria in the
presence of sub-lethal concentrations of the peptides (Ge et al., 1999; Mosca et al.,
2000; Tew et al., 2002). From this background, we hypothesized that naturally occurring
bloodstream HDPs especially from platelets could be responsible for killing of P.
falciparum early in erythrocytic infection, aside from cerebral malaria symptomology.
Identification of human platelet factor 4 (hPF4) as an antiparasitic HDP that kills P.
falciparum via lysis of the parasite DV
A screen of HDPs normally found in the bloodstream, secreted by a variety of cells
including platelets, neutrophils, or lymphocytes, was performed to assess their antiparasitic activity (Figure 19A). This screen revealed that several proteins killed P.
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falciparum in vitro without affecting the host erythrocyte. Most notably, hPF4 showed
high potency against P. falciparum with an IC50 of 4.2 µM and no significant hemolysis.
Considering local concentrations of hPF4 have been reported to reach at least 280 µM
surrounding activated platelets (Kowalska et al., 2010), the antiparasitic IC50 of hPF4 has
in vivo relevance. We thus focused our efforts on studying PF4 to determine the
biological relevance of its potential antimalarial properties. Platelets harvested from wildtype (WT), mouse PF4 (mPF4) knock-out (mPF4 KO), or overexpressing hPF4 (hPF4+)
mice were tested against P. falciparum in culture with recombinant mPF4 and hPF4 as
controls (Figure 19B). Pre-activated WT and hPF4+ mouse platelets were able to kill P.
falciparum in culture, while littermate PF4 KO platelets showed no killing capacity. Thus
it appears that PF4 is the major antimalarial component of activated platelets.
As membrane perturbation is an established mechanism of action for HDPs
(Burkhard, 2009; Lehrer et al., 1989; Matsuzaki et al., 1997; Westerhoff et al., 1989;
Zasloff, 2002), we examined the integrity of potential target parasite membranes upon
hPF4 treatment. Since hPF4 had little hemolytic capability we reasoned the erythrocyte
integrity was not significantly compromised. Parasite plasma membrane (PPM) potential
assays showed no discernible loss of potential following 4 hours of hPF4 exposure
(Figure 19C). Next the integrity of established intracellular organelle targets, including
the mitochondria and lysosome-like DV was assessed post hPF4 treatment. Analysis of
membrane potential revealed no perturbation of the mitochondria, however a significant
loss of proton potential was observed in the DV within minutes of treatment (Figure
19C). To further investigate this novel perturbation to the DV, transgenic parasites
expressing green fluorescent protein (GFP)-tagged plasmepsin II in the DV (Klemba et
al., 2004) were treated with hPF4 and followed by fluorescence microscopy over a 10	
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minute time course. Parasites were assayed for both hPF4 localization using
immunofluorescence analysis (IFA) and direct GFP signal (integrity of the DV; Figure
19D). Within 1 minute of hPF4 incubation, hPF4 staining could be detected in the
cytoplasm of only infected erythrocytes. hPF4 continued to accumulate over the next
several minutes, wherein it entered the parasite cytoplasm and colocalized with the
parasite DV. Next, severe perturbation of the DV allowed GFP to diffuse throughout the
parasite cytoplasm (Figure 19D, Figure 20A,B). Western blot analysis of hPF4
confirmed the IFA results showing entry into erythrocytes by 1 minute followed by
accumulation into the parasite within 5 minutes (Figure 19E). To assess the loss of DV
integrity on the population level, we utilized ImageStream flow cytometry to first capture
images of individual parasite-infected cells, then quantitatively differentiate based on DV
fluorescent surface area (SA) intact DVs (<0.2 µm2) from lysed DVs (>2 µm2; Figure
19F, Figure 20C). hPF4 treatment caused dose-dependent DV lysis, with nearly
complete DV lysis on a population level upon exposure to 10 µM hPF4. The loss of DV
integrity was confirmed at high resolution using transmission electron microscopy
imaging to compare untreated and hPF4-treated parasites revealing the complete loss of
DV integrity in the hPF4-treated parasites versus mock-treated parasites with a clearly
delineated DV membrane (white arrowheads; Figure 19G). In addition to the loss of DV
organellar structure, hemozoin crystals were seen dispersed throughout the parasite (red
arrowheads). Thus, DV lysis appears to be the primary and novel mechanism of hPF4
action against parasites.
In contrast, the only other human HDP tested against P. falciparum is NK-2, secreted
by lymphocytes, which was shown to kill P. falciparum by direct perturbation of the
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infected erythrocyte plasma membrane (Gelhaus et al., 2008). Dermaseptins, HDPs
from the skin of hylid frogs, were demonstrated to kill parasites by perturbation of the
infected erythrocyte plasma membrane or the parasite plasma membrane (Dagan et al.,
2002; Ghosh et al., 1997). However, the high hemolytic potential of dermaseptins and
the fact they are not of human origin makes the therapeutic relevance of these findings
unclear.

Though the mode of entry into cells is unclear, given that there are 4

membrane systems that must be bypassed prior to selective interaction with the DV
membrane, we provide evidence that hPF4 enters only infected erythrocytes and that
this entry process can be blocked by protamine sulfate (Figure 20D). This indicates the
importance of initial electrostatic interactions with the infected host cell membrane or
membrane proteins. Stage specificity studies indicate that hPF4 is most potent during
parasite stages that heavily rely on digestive vacuole function (Figure 20E), perhaps
indicating that hPF4 is incorporated into the parasite body during hemoglobin uptake.
In order to obtain proof of concept that HDPs kill parasites in blood stage malaria
infection, we tested PF4 in a non-experimental cerebral malaria (non-ECM) murine
malaria model using the 4-day Peters suppression test (Knight and Peters, 1980). Mice
infected with P. yoelii 17XNL were administered 10 mg/kg mPF4 intravenously on days
1-3, and parasitemias were assessed on day 4. mPF4 treatment significantly reduced
parasitemia by 4-fold (Figure 20F).
Synthetic small molecule HDP mimics are potent against P. falciparum and have a
mechanism similar to hPF4
Given their broad activity, HDPs appear to be ideal therapeutic agents, though
significant pharmaceutical issues have severely hampered clinical progress, including
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poor tissue distribution, systemic toxicity, and difficulty and expense of manufacturing
(Easton et al., 2009). In addition, PF4 has been reported to worsen experimental
cerebral pathology in mice, presumably mediated through the chemokine domain
(Srivastava et al., 2008). Thus, we reasoned that synthetic small molecules capable of
adopting amphipathic secondary structures analogous to an HDP could potentially
reproduce the potent, selective antiparasitic activity of PF4, while improving tissue
distribution and decreasing complications arising from chemokine signaling. In addition,
these small molecule HDP mimics (smHDPs) are significantly less expensive to produce
(an example scaffold is shown in Figure 21A). In order to exploit the DV lysis
mechanism of PF4 in a drug discovery effort, a library of ~1000 non-peptidic smHDPs
(Mensa et al., 2011; Scott et al., 2008) was tested against P. falciparum. 132
compounds were determined to be initial “hits” (14.3% hit rate), using a cutoff of 80%
parasite death at 1 µM (Z’ = 0.720; Figure 21B). 74 compounds were selected for
follow-up IC50 determination (Table 6). Based on these hits, additional compounds were
synthesized and 7 structurally diverse compounds were chosen as “leads” based on
high potency against P. falciparum, low hemolytic potential, and low mammalian cell
cytotoxicity. These lead compounds also showed similar potency across a panel of
chloroquine-sensitive (3D7, HB3) and chloroquine-resistant (Dd2, 7G8, K1) parasite
lines, both lab-adapted (Table 7) and short-term adapted field isolates (Table 8).
Several of the lead compounds displayed little activity against Gram-positive and Gramnegative bacteria, as well as mammalian cells, indicating that a high level of specificity
can be built into these non-peptidic scaffolds that can distinguish between prokaryotic
and eukaryotic pathogens. Although all lead compounds showed a similar mechanism of
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action as PF4, based on acute animal tolerability studies, PMX1207 and PMX207 were
selected for more rigorous mechanistic analysis.
Treatment of P. falciparum parasites with either PMX1207 or PMX207 disrupted DV
membrane integrity within 15 minutes of treatment but did not disturb the PPM or
mitochondrial potential, even after 4-hour treatment (Figure 22A). In addition, treatment
of the transgenic PMII-GFP parasites with PMX1207 and PMX207 resulted in rapid
diffusion of GFP through the parasite cytoplasm indicating a catastrophic loss of DV
membrane integrity in a manner similar to that observed for hPF4 (Figure 22B).
ImageStream flow cytometry analysis indicated a dose-dependent effect on DV lysis,
with nearly complete DV lysis within the treated population upon treatment with 1 µM of
PMX207 or PMX1207 (Figure 22C). Similarly, 7 additional smHDPs showed rapid lysis
of the DV upon treatment (Figure 23A).
We further investigated the intracellular localization and distribution of the smHDPs
using PMX496, a potent smHDP with intrinsic fluorescence. PMX496 appeared to
accumulate in the parasite body within 30 seconds, then concentrated in the DV at 1
minute, prior to dissipation throughout the parasite body, indicating a loss of DV
membrane integrity (Figure 23B). Since cationic amphipathicity is predicted to be
necessary for smHDP antiparasitic action, an uncharged isosteric analog of PMX496
was synthesized (PMX1269, IC50 > 2.5 µM). As expected, treatment with the uncharged
analog did not result in DV lysis. High-resolution transmission electron microscopy and
3D tomograms revealed a complete loss of integrity of the DV after treatment with either
PMX1207 or PMX207 (Figure 22E). In addition to free hemozoin crystals (red
arrowheads), images showed an accumulation of undigested hemoglobin-containing
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vesicles (yellow arrowheads; Figure 22E, Figure 23E). Mock-treated parasites showed
clear delineating DV membranes (white arrowheads). DV lysis and killing was also
evident in Texas Red Dextran-loaded erythrocytes infected with either trophozoite-stage
parasites (Figure 23C) or gametocytes (Figure 23D). Although we cannot discern
whether gametocytes are dying from this data, loss of DV integrity would likely result in
death and this possibility indicates that smHDPs may have transmission-blocking
potential.
smHDP activity reduces parasitemia in a murine malaria model
In order to further explore the antimalarial properties of lead smHDPs, PMX207 and
PMX1207 were assessed for their ability to limit parasite growth in vivo. PMX207 and
PMX1207 antiparasitic activity was assessed in a non-ECM murine malaria model using
the 4-day Peters suppression test (Figure 22E). Mice were inoculated intravenously on
day 1 with 2 x 105 P. yoelii XNL-infected erythrocytes and then treated with 10 or 20
mg/kg of PMX207, 5 mg/kg PMX1207, or vehicle alone for 3 days and parasitemias were
monitored on day 4. PMX207 showed a dose-dependent decrease in parasite growth,
with 20 mg/kg, almost completely eliminating parasitemia (Figure 22F,G). PMX1207
showed a significant decrease in parasite growth, suppressing parasitemia 5-fold over
vehicle-treated controls. These data provide in vivo validation that smHDP compounds
show promise as a new class of antimalarials.
Discussion
HDPs are extremely diverse not only in structure, but in cellular targets and mode of
action. HDPs have been shown to kill pathogens via a variety of mechanisms: simply via
perturbation of the pathogen plasma membrane (Chao and Raines, 2011; Duchardt et
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al., 2007; Haines et al., 2009; Mochon and Liu, 2008) or intracellular membranes such
as mitochondria (Slaninova et al., 2012), or through immune modulation (D'Este et al.,
2012; Repeke et al., 2011; Williams et al., 2012; Wuerth and Hancock, 2011). However,
there is a distinct lack of examples that involve perturbation of pathogen
endosomes/lysosomes, aside from the killing of the distantly related protozoan parasite,
T. brucei brucei, in an HDP-like manner by a human protein, trypanosome lytic factor
(TLF). TLF has been shown to cause lysis of parasite endosomes/lysosomes conferring
a species barrier and protection for humans against infection (Harrington et al., 2009;
Rifkin, 1978; Samanovic et al., 2009; Smith et al., 1995).
Finally, we present a model for the mechanism of action for these HDPs or small
molecule mimics, which begins upon uptake of these molecules into the host erythrocyte
cytoplasm, possibly through a parasite-mediated mechanism (Figure 24A). Once inside
the host cell cytoplasm, these HDP molecules are targeted to the DV along with
hemoglobin through the cytostome (Goldberg, 1993) and carried to the DV via
hemoglobin-containing vesicles. Once inside the DV, the HDP or smHDP is released
along with the hemoglobin cargo, accumulates and binds to the membrane directly. At a
critical concentration, these HDPs disrupt the integrity of the DV membrane and release
the contents, which include numerous proteases and hydrolases, into the cytoplasm of
the parasite (Figure 24B). Destruction of proteins and organelles leads to rapid parasite
death (Figure 24C).
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Table 6
Compound
Chloroquine
Artesunate
004
015
018
033
048
053
056
058
062
073
092
112
143
146
152
158
160
192
201
207
217
224
235
256
270
459
462
474
484
485
493
496
501
504
610
611

3D7 IC50 (nM)
8.7
19.4
563
438
668
306
295
740
653
1233
413
204
1024
688
870
322
221
683
151
1198
125
153
569
893
146
1064
732
1365
1283
991
655
841
904
160
593
160
N/A
60

Dd2 IC50 (nM)
24.6
12.1
740
601
611
419
484
1154
993
1219
426
274
713
740
688
244
170
827
168
1010
85
134
591
524
108
344
803
1632
2120
1226
1095
1006
1183
170
393
118
N/A
49

Compound
614
616
617
633
647
651
661
730
731
734
781
800
819
832
835
847
848
868
893
1007
1011
1012
1032
1045
1064
1065
1068
1070
1076
1086
1088
1095
1096
1099
1101
1107
1115
1120

3D7 IC50 (nM)
864
149
110
272
160
148
175
1150
1164
610
147
610
724
358
220
870
625
881
200
1283
880
656
1197
706
1098
680
644
650
N/A
812
734
1141
58
1163
672
1102
696
308

Dd2 IC50 (nM)
966
97
172
457
300
267
200
975
964
980
207
431
951
368
300
1076
709
886
301
2747
795
555
798
398
1132
664
682
724
N/A
1054
602
786
90
667
656
997
829
331

1154
1158
1159
1164

530
563
493
N/A

N/T
N/T
N/T
N/T

1284
1287
1301
1302

160
2819
226
160

135
N/T
N/T
132
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1165
1170
1179
1185
1199
1200
1201
1206
1207
1209
1210
1211
1213
1219
1220
1221
1222
1223
1224
1226
1229
1237
1249
1258
1260
1267
1268
1269
1271
1283
N/A = Not Active
N/T = Not Tested

161
81
1125
15.5
2932
2681
3376
3284
110
1503
658
976
N/A
3050
N/A
N/A
3603
3079
297
2523
202
255
1716
247
N/A
N/A
3480
3029
2318
2445

N/T
N/T
N/T
N/T
N/T
N/T
N/T
N/T
75
N/T
N/T
N/T
N/T
N/T
N/T
N/T
N/T
N/T
N/T
N/T
N/T
N/T
N/T
N/T
N/T
N/T
N/T
N/T
N/T
N/T

1305
1306
1307
1308
1310
1324
1325
1338
1364
1374
1375
1382
1387
1398
1399
1400
1403
1407
1408
1410
1411
1412
1413
1414
1415
1416
1417
1418
1422

N/A
1299
1256
629
2203
602
112
N/A
N/A
641
88.3
126
N/A
131
N/A
473
116
795
77.1
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
187
738

N/T
N/T
N/T
N/T
N/T
N/T
N/T
N/T
N/T
N/T
N/T
N/T
N/T
N/T
N/T
N/T
N/T
N/T
N/T
N/T
N/T
N/T
N/T
N/T
N/T
N/T
N/T
N/T
N/T

Table 6. IC50 values determined in 3D7 (CQ-sensitive) and Dd2 (CQ-resistant) P. falciparum for 74 hits from
smHDP screen and derivative compounds not included in original screen. Parasites were treated in
triplicate, n = 2.
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Table 7

Table 7. smHDPs show potency across several chloroquine-sensitive and chloroquine-resistant P.
falciparum strains, with little cytotoxicity against mammalian cells. Lead smHDPs were screened
against a panel of chloroquine-sensitive and chloroquine-resistant P. falciparum lines. Chloroquine was used
as a positive control for parasite death. IC50s are as mean ± SEM, n>3 for each compound. Cytotoxicity
(EC50) determined against mouse 3T3 fibroblasts and human transformed liver HepG2 cells using an MTS
viability assay.

Table 8

Table 8. Lead smHDPs show potency across several chloroquine-sensitive and chloroquineresistant P. falciparum field isolates. Lead smHDPs were screened against a panel of chloroquinesensitive and chloroquine-resistant P. falciparum lines. Chloroquine was used as a positive control for
parasite death. IC50s are as mean ± SEM, n>3 for each compound. Cytotoxicity (EC50) determined against
mouse 3T3 fibroblasts and human transformed liver HepG2 cells using an MTS viability assay.
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(A) Screen of human HDPs found in blood for P. falciparum killing and hemolysis at 15 µM, including Regulated upon Activation,
Normal T-cell Expressed, and Secreted (RANTES); hPF4; Fibrinopeptide-A (FP-A); Fibrinopeptide-B (FP-B); Human Neutrophil
Peptides 1 and 2 (HNP-1; HNP-2); Cathelicidin (LL-37). Parasite survival was normalized to an untreated control. Artesunate (500 nM)
and the HDP melittin (15 µM) were used as positive controls for parasite death without and with hemolysis, respectively. Data shown
8
are means ± SEM. (B) Parasite-infected erythrocytes were incubated for 24 hours with 2.5 x 10 platelets from either littermate WT, PF4
KO, or hPF4+ mice in the presence or absence of 5 µM AYP to induce platelet activation. Parasite survival assayed by flow cytometry
using SYTOX green as a measurement of DNA content and normalized to an untreated control. Recombinant hPF4 and mPF4 (10 µM)
were used as positive controls. Data shown are means ± SEM.

Figure 19. hPF4 acts as a HDP against P. falciparum via lysis of the
parasite DV. (A,B)
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Figure 19. hPF4 acts as a HDP against P. falciparum via lysis of the
parasite DV. (C-E)

(C) Parasite-infected erythrocytes pre-incubated with rhodamine 123 (1 µM for parasite plasma membrane
potential; 0.2 µM for mitochondrial potential) or 10 nM LysoTracker Red and then treated over a 4-hr time
course with 10 µM PF4 or a 10 µM mixture of ionophores Monensin and Nigericin (Mon/Nig). Length bar is
10 µm in each figure. (D) hPF4 accumulates in the infected erythrocyte cytoplasm prior to lysis of the DV by
immunofluorescence. Erythrocytes infected with parasites expressing plasmepsin-II-GFP (PM-II-GFP) were
treated with 1 µM hPF4 over a 10 min time course. Within 1 minute of PF4 incubation, PF4 staining is seen
in the cytoplasm of infected erythrocytes until entering and inducing lysis of the parasite DV, as shown by
GFP signal diffusion through the entire parasite cytoplasm. (Green: PM-II-GFP [DV]; red: hPF4 IFA; blue:
parasite nuclei.) (E) Western blot analysis of erythrocyte fractions or parasite lysates shows early
accumulation of hPF4 in infected erythrocytes, followed by persistence in the parasite.
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Figure 19. hPF4 acts as a HDP against P. falciparum via lysis of the
parasite DV. (F, G)

(F) ImageStream flow cytometry shows a dose-dependent increase in PM-II-GFP parasites with a
2
fluorescence surface area of >2 µm , an indication of DV lysis, upon treatment with hPF4. Intact DVs have
2
fluorescent surface areas <0.2 µm . Data shown are means ± SEM. (*p<0.05, **p<0.01) (G) TEM images
reveal dissolution of the DV membrane upon treatment with 10 µM PF4, as well as dispersal of hemozoin
fragments throughout the cytoplasm (red arrowheads). Mock-treated controls showed complete integrity of
the DV membrane (white arrowheads), encapsulating all hemozoin crystals. (N: parasite nucleus).
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Figure 20. hPF4 causes dose-dependent DV lysis and reduces
parasitemia in a mouse malaria model. (A-C)	
  

	
  
	
  
	
  

	
  (A) Trophozoite-infected Texas Red Dextran-loaded erythrocytes show dispersal of fluorescence into the

parasite cytoplasm (indicating DV lysis) following 5 min of treatment with hPF4. (B) Gametocyte-infected
Texas Red Dextran-loaded cells show dispersal of fluorescence into the parasite cytoplasm (indicating DV
lysis) upon 5 min of treatment with hPF4. (C) Representative flow plots from mock-treated parasites
expressing PM-II-GFP or parasites treated with 1 µM hPF4, 3 µM hPF4, or 10 µM hPF4. Synchronous PM-II
parasites were used to examine DV integrity upon treatment. DV lysis is defined as area of GFP signal
2
greater than 2 µm (red line is minimum area), as GFP signal would disperse into the entire parasite
2
cytoplasm. Intact DVs show compact area (less than 0.2 µm ; blue line is maximum area).
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Figure 20. hPF4 causes dose-dependent DV lysis and reduces
parasitemia in a mouse malaria model. (D, E)	
  

(D) PM-II-GFP parasite-infected erythrocytes were pretreated with 5 mM protamine sulfate or mock (DMSO)
or 30 minutes, then treated with 10 µM hPF4 for 10 minutes prior to fixation and permeabilization. hPF4
immunofluorescence (red) shows no appreciable signal in the protamine sulfate pretreated erythrocytes,
while mock-pretreated erythrocytes show hPF4 accumulation within the erythrocyte. (red: hPF4 IFA; green:
PM-II-GFP; blue: parasite nuclei). (E) Stage-specific killing of PF4 shows increased efficacy during the
stages that rely heavily on DV function (late ring, trophozite, schizont, gametocyte). Shown are means ±
SEM; n=3.
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Figure 20. hPF4 causes dose-dependent DV lysis and reduces
parasitemia in a mouse malaria model. (F)

	
  
(F) Mice infected with P. yoelii 17XNL show decreased parasitemia on day 4 when treated with 10 mg/kg
mPF4 (n=3) compared to controls (n=5, p < 0.001). Shown are mean parasitemias ± SEM.	
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Figure 21. Screen of smHDPs reveals potent inhibitors of
P. falciparum growth.

(A) Conceptual design of smHDPs from HDPs. Top: Amphipathic structure of magainin 2; cationic groups in
blue, nonpolar groups in green, peptide backbone in yellow. Bottom: de novo designed smHDPs capture the
facially amphipathic architecture and critical physicochemical properties needed to establish robust
antimicrobial activity. (B) Screen of 920 smHDPs at 500 nM against P. falciparum. Parasite death was
normalized to a chloroquine control (14.3% hit rate, Z’ = 0.720).
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Figure 22. smHDP leads kill P. falciparum via parasite DV lysis and
decrease parasitemia in a murine malaria model.

(A) Parasite plasma membrane and mitochondrial potential were examined during treatment with PMX207
or PMX1207, with no discernible loss of fluorescence, unlike the positive controls. Compromise of DV
integrity was monitored with LysoTracker Red, wherein loss of DV fluorescence was seen within 15 min of
smHDP treatment, though no loss of parasite plasma membrane potential occurs. (B) Loss of DV integrity
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upon smHDP treatment of PM-II-GFP P. falciparum parasites (Green: PMII-GFP [DV]; blue: parasite nuclei.)
(C) ImageStream flow cytometry shows a dose-dependent increase in PM-II-GFP parasites showing a
2
fluorescence surface area of >2 µm , an indication of DV lysis, upon treatment with PMX207 or PMX1207.
2
Intact DVs have fluorescent surface areas <0.2 µm . Data shown are means ± SEM. (*p<0.05, **p<0.01) (D)
TEM images reveal complete dissolution of the DV membrane upon PMX207 or PMX1207 treatment, with
dispersal of hemozoin crystals (red arrowheads) throughout the cytoplasm and an accumulation of
undigested hemoglobin-containing vesicles (yellow arrowheads). Mock-treated parasites retained a clear
delineating DV membrane (white arrowheads), encapsulating all hemozoin crystals. (N: parasite nucleus).
(E) Parasitemias of Swiss Webster mice infected with P. yoelii 17XNL parasitized erythrocytes via i.v.
injection and treated with vehicle (n=5); 5 mg/kg PMX1207 (n=7); or 20 mg/kg of PMX207 (n=5).
Parasitemia was assessed on days 4 and 6. Shown are the means ± SEM. (*p<0.05; ***p<0.001) (F)
Parasitemias of C57Bl/6 mice infected with P. berghei ANKA parasitized erythrocytes via i.v. injection and
treated with vehicle (n=10); 5 mg/kg PMX1207 (n=5); or 20 mg/kg of PMX207 (n=5). Parasitemia was
assessed on days 5 and 7. Shown are the means ± SEM. (*p<0.05; ***p<0.001). (G) Survival curves for P.
berghei ANKA infected mice. p = 0.14 in the log-rank Mantel-Cox test.
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Figure 23. smHDPs require a facial charge density to lyse the parasite
DV.

(A) Visualization of DV lysis by smHDPs by fluorescence microscopy. PM-II-GFP P. falciparum parasites
were treated with compounds PMX504, PMX611, PMX647, PMX835, PMX496, or PMX1269 (250 nM) over
a 5-min time course and imaged via fluorescent microscopy. In untreated parasites, the GFP signal is an
isolated structure, indicating an intact DV. The GFP signal after smHDP treatment spans the entire parasite
body, indicating loss of digestive vacuole integrity. The uncharged analogue of PMX496, PMX1269, did not
cause DV lysis. (Green: PM-II-GFP; blue: parasite nuclei.) (B) Fluorescent microscopy of the intrinsically
fluorescent PMX496 shows accumulation within the parasite cytoplasm and DV prior to DV lysis. (C,D)
Visualization of DV lysis by PMX1207 with Texas Red Dextran-loaded erythrocytes. Trophozoite- (C) or
Gametocyte-infected (D) Texas Red Dextran-loaded cells show dispersal of fluorescence into the parasite
cytoplasm following treatment with PMX1207, indicating loss of DV integrity. (E) Number of hemoglobincontaining vesicles in electron micrographs of parasites treated with 10 µM hPF4, 500 nM PMX207, or
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500nM PMX1207 was counted and compared to mock (DMSO)-treated controls. Data shown is mean ±
standard deviation of 50 parasites (*p<0.05).

Figure 24

Figure 24. Model of PF4 and smHDP uptake. Proposed mechanism of parasite uptake of PF4 and
smHDPs. (A) Molecules reach the host erythrocyte cytoplasm, possibly via either an active mechanism
(Route 1) or a passive mechanism (Route 2) initiated by the parasite during hemoglobin uptake through the
cytostome (c) and packaging into double membranous hemoglobin-containing vesicles (HV). HVs are then
targeted to the DV where the contents are released into the DV lumen. (B) As the parasite continues to take
up host cell cytoplasm, the HDPs or derivatives eventually reach a critical concentration within the DV, bind
to the inner leaflet of the DV membrane, and disrupt its integrity, allowing the contents to enter the
cytoplasm of the parasite. (C) Rapid destruction of proteins and organelles cause parasite death.

	
  119	
  
	
  

VII. CONCLUSIONS AND FUTURE DIRECTIONS
Through focused characterization of host-parasite interactions that could be
exploited to strengthen development of novel antiparasitics, we hoped to achieve
a paradigm shift to establish that multiple host proteins/pathways are essential
for apicomplexan parasite growth, and may be exploited to generate novel drug
classes with limited propensity for resistance. In addition, we wished to establish
commonalities and differences between the distantly related apicomplexan
parasites, Toxoplasma and Plasmodium, with the hope that these common host
proteins co-opted by these parasites might be used by other protozoa such as
the poorly studied, biodefense class B parasite Cryptosporidium parvum.
Ultimately, the concept of inhibiting host factors necessary for parasite growth or
optimizing innate antiparasitic molecules may prove an effective therapeutic
strategy for multiple intracellular parasites, as inhibition of these targets will
necessarily limit drug resistance. We hope that one or more host proteins will
emerge as novel therapeutic targets or provide the basis for novel therapeutics
that will drive antiparasitic drug development.

Targeting host molecules required for parasite life cycle progression:
Can we beat them at their own game?
An assessment of the parasite life cycle allowed us to identify necessary interactions
with the host, without which the parasite would be unable to proliferate: it is clear that the
parasite interacts with the host upon invasion, to obtain nutrients, and ultimately to lyse
and leave the host cell. As the process of parasite egress was not well characterized
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relative to the process of invasion, we believed that this process likely provided a wealth
of untapped resources for antiparasitic drug development: they only had to be
characterized. This act of egress is thought to take place in seconds at the end of the
48-hour erythrocytic cycle through the complete destruction of the host erythrocyte.
From our prior work demonstrating that parasites require human calpain [15], we
hypothesized that host calpain is used to destabilize the erythrocyte membrane. In this
work, we endeavored to provide a more global understanding of changes that occur to
the host erythrocyte membrane proteome during parasite egress and furthered identified
a complex GPCR-driven host pathway necessary for cytoskeletal compromise prior to
parasite release.
Together, these data suggest that parasite egress does not occur as a single
explosive event just at the end of the 48-hour life cycle. More accurately, the distinct
events of cytoskeletal dismantling, which we now demonstrate, suggest a systematic
preparation for egress that takes place over at least 15-20 hours in which the parasite
gradually disrupts the cytoskeleton to ultimately allow for facile escape. Though this work
represented a concentrated effort, we submit that these results do not provide an
exhaustive identification of host protein involvement in parasite growth. A combination of
genetic, proteomic, biochemical, and in vivo approaches will likely be required to
systemically identify and characterize host proteins required for parasite life cycle
progression through invasion, replication, and egress:

1. Genome-wide screens to define host genes involved in T. gondii growth.
Aside from our data implicating multiple host proteins during parasite egress
(Chandramohanadas et al., 2009) and host actin polymerization (Gonzalez et al., 2009)
during parasite invasion no host proteins have been identified to be required for
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intracellular parasite replication or growth. To determine additional host factors involved
in this process using an unbiased approach to identify host genes important for parasite
growth, systematic knockdown using should be used.

2. Targeted siRNA screen for host proteins involved in parasite invasion.
Though we have made significant strides in the study of host proteins that function in
parasite exit, little is known about host proteins involved in parasite invasion. In fact, it
has historically been assumed that the host cell remains quiescent during this process,
as much attention has been paid to parasite-derived proteins that function in invasion.

3. Quantitative proteomics studies to discover host proteins that change in
response to T. gondii infection.
As a complementary approach, quantitative proteomics studies will allow the
determination of host proteins that change in abundance during parasite infection. This
approach will involve the use of SILAC-labeling and mass spectrometry-based
sequencing (Ong et al., 2002) in host cells to discover new host-parasite interactions.
Proteins that significantly change in abundance (>3 fold change) up or down may
represent host proteins modified directly or indirectly by the parasite to allow for
progression of its life cycle.
4. Assessing the role of host proteins during parasite infection in vivo.
While we have demonstrated that calpains have a key role in parasite egress in cell
culture models (Chandramohanadas et al., 2009), it is important to explore the in vivo
physiological importance of the GPCR and calpain-mediated egress pathway using
mouse models of parasite infection. Validation of this pathway in animal models would
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provide an important proof of principle to justify future therapeutic development.
Importantly, although calpain-2 is essential for embryonic development, pharmacological
inhibition of calpain-1/2 in adult mice was well tolerated (Mamoune et al., 2003) and
genetic ablation of both calpain-1 and calpain-2 using tissue-specific or regulated
conditional CAPN4 knockout approaches have resulted in viable mice with subtle
physiological defects (Kashiwagi et al.; Shimada et al., 2008; Tan et al., 2006;
Wernimont et al.). Furthermore, knockout approaches involving multiple PKC family
members have been unsuccessful. Collectively, these observations bode well for the
potential clinical use of selective and effective inhibitors, as well as conditional knockout
systems.
Mice that are either heterozygous or homozygous knockouts of any of host gene
“hits” from the RNAi screen should be challenged with both T. gondii, P. yoelli, and P.
berghei ANKA. The mouse malaria model P. yoelii is useful as this species models
severe non-cerebral malaria, the time course of infection is short, and the outcome
(survival vs. lethality) is definitive. The P. berghei ANKA mouse model, in contrast,
models cerebral malaria, allowing for differential investigation of host protein involvement
in different models of disease. The effect of genetic depletion of screen hits on parasite
infection should be compared with that achieved using standard anti-malarial drugs
including artemisinin and atovaquone, as well as that seen using specific inhibitors.

PF4 and Small molecule mimics of host defense peptides:
Can we optimize an evolutionarily-tuned host defense?
In addition to identifying host proteins exploited by the parasite for life cycle
progression, we were interested in characterizing host proteins that naturally act as
antiparasitics via exploitation of a fundamental host-parasite interaction.
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In this work we identified the human HDP protein, PF4, as an antiparasitic molecule
that kills Plasmodium parasites by lysing the parasite DV, a vital parasite organ
responsible for digestion of host hemoglobin. Targeting the lysosome-like vesicles of
protozoan parasites may be an evolutionarily selected mechanism for mammalian hosts
to kill Plasmodium and other parasites (i.e. T. brucei). How proteins such as PF4 enter
host cells remains an open question, though uptake of hPF4 into the host erythrocyte
seems to diminish following parasite DV lysis and parasite death, suggesting that
perhaps an active, parasite-mediated mechanism allows entry of these HDP molecules
into the erythrocyte cytoplasm. Since only infected cells are targeted, and parasite
viability is important for uptake, this suggests that perhaps a parasite-derived or
activated endocytosis-like mechanism could allow for large molecules such as PF4 to
enter, while perhaps channels or pores could be responsible for small molecule uptake
(Baumeister et al., 2006; Elford et al., 1990; Kirk and Horner, 1995).
We believe that human PF4 likely has a natural role in controlling blood stage
parasite growth, and that its low hemolytic potential and selective targeting of the
parasite DV endow it with properties that are well tolerated in the bloodstream. However,
it is unlikely that PF4 would make a useful therapeutic for malaria treatment due to the
cost of goods, and potential of inflammatory damage through its chemokine domain
during cerebral malarial. Thus screening for smHDPs with a similar mechanism of action
may avoid the issues of PF4 while preserving its unique mechanism of action and safety;
as such, smHDPs may represent a new class of small molecules with effective
therapeutic potential for combating this human disease where efforts are currently
challenged with rampant drug resistance. In order to optimize these molecules as potent
antiparasitics, it will be necessary to understand the unique properties of parasite
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membranes that engender this specificity and the PF4 domains responsible for this
antiparasitic activity, as well as resistance studies, development of analogues, and in
vivo studies:

5. Testing PF4 against model liposomes based on the composition of
parasite digestive vacuolar membranes. To determine why PF4 selectively
disrupts the digestive vacuole membrane causing leakage of digestive vacuole contents
via direct membrane disruption, model liposomes with similar lipid content to the parasite
digestive vacuole membrane should be prepared prior to assessment of membrane
compromise upon PF4 treatment. The composition of parasite digestive vacuole
membranes can be determined via the isolation of this organelle from whole parasites
(Goldberg et al., 1990) and analysis of lipid content within these purified preparations via
Liquid Chromatography/Mass Spectrometry (LCMS) (Ham et al., 2004).

6. Understanding the basis of selective entry of PF4 into infected
erythrocytes. Our preliminary data shows that only infected erythrocytes take up PF4
and that pretreatment with protamine sulfate blocks both entry and activity of PF4
against P. falciparum. This allows us to hypothesize that initial interaction between PF4
and the parasitized erythrocyte is electrostatic and involves binding to negatively
charged molecules on the surface. Considering that the erythrocyte surface proteins
such as the glycophorins are highly decorated with sialic acid, we can directly test
whether sialic acid is involved in the initial binding events by specifically stripping it off
using neuraminidase.

7. Generating PF4-resistant parasites. Since HDP-mediated cell death via
membrane perturbation is not reliant upon a specific receptor or intracellular protein
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target, cellular resistance to such compounds should be difficult to generate. In order to
test this hypothesis, P. falciparum lines that are resistant to PF4 should be attempted to
be generated via serial passaging in dilutions of our experimentally determined PF4 IC50
(0.25 x IC50, 0.5 x IC50, and the full IC50 concentration). As a control, parallel cultures
should also be exposed to 0.5x IC50 concentration of pyrimethamine, a well-established
antiparasitic for which resistance has been reported. This should be carried out over a
time period of at least 6 months. If resistant lines are successfully generated, tiling
microarrays should be used to determine any genes that contribute to resistance.
Resistance would indicate that PF4 might not be acting solely via membrane disruption.
Conversely, if parasites fail to generate resistance to these compounds, this class of
compounds may have potential as antimalarials that may elicit minimal parasite
resistance.

8. Assessing the in vivo role of PF4 during parasite infections in genetically
modified mice.
PF4 (CXCL4) belongs to the CXC family of chemokines that has a putative HDP domain
at the C-terminus. PF4 can be released upon activation from alpha-granules of blood
platelets in very high physiologic concentrations, locally up to 100 mM (Lambert et al.,
2007b). Until recently, CXCL4 gene expression was thought to be restricted to
megakaryocytes (Brandt et al., 2000), but other cell types may produce these
chemokines as well (Schaffner et al., 2005). The Poncz laboratory was the first to
develop PF4 knockout mice (Eslin et al., 2004b) and also transgenic mice that
overexpress human PF4 (hPF4+; (Zhang et al., 2001)). These mice are valuable tools
for the study of PF4 in vivo in several disease models including thrombus formation,
atherosclerosis, megakaryopoiesis, liver fibrosis, angiogenesis and tumor formation. In
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this proposal we aim to use these mice to understand the in vivo relevance of platelet
secreted PF4 in both the severe anemic model of malaria using P. yoelii (which causes
disease in the peripheral vasculature and organs) versus a model of experimental
cerebral malaria caused by P. berghei ANKA (which causes pathology in the brain of
mice).

9. Identification of antiparasitic domains within PF4. PF4 is comprised of three
domains:

an

N-terminal

cytokine

domain,

a

central

domain

responsible

for

tetramerization, and a C-terminal amphipathic helical region with HDP activity (C12). We
have evidence that C12 retains the ability to kill parasites, at reduced potency, and that 2
of 4 lysines on the positive face of this peptide are required for activity. Using this
information we can hypothesize that these properties will also be present in the full
length protein. We hypothesize that the need for 2 positive charges to maintain facial
amphipathicity in the α-helical domain of PF4 will also be true in the full-length protein.
To test this, we could recombinantly express full-length PF4, mutating all lysines
individually and in combinations of doubles, triples, and a quadruple mutant to determine
not only if two lysines are necessary for HDP activity, but also if specific lysines are
important. The resultant proteins will then be tested against P. falciparum in culture, and
activity of the PF4 mutants will be compared to wild type PF4 to assess for IC50 trend
and antimalarial activity.

10. Development of peptidomimetics based on the HDP domain of PF4. In an
effort to further understand the interaction of PF4 antimalarial activity and generate tools
for use for in vivo mouse malaria studies, we will synthesize an array of derivatives
based on the C12 domain of PF4 via standard synthetic routes. The underlying principle
to the generation of these C12-based tool compounds is to increase their stability and
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potency in vitro and in vivo while maintaining low host toxicity. Ultimately, this will build
the knowledge for future efforts to produce a biological therapeutic for malaria.
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